Symptoms and signs involving the nervous and musculoskeletal systems

R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R25-R29 Cause of death: ICD-10 — R25-R29 2 out of 7 registries used, show all original rules.	35255
4. Check minimum number of events None	35255
5. Include endpoints R18_ABNORMAL_INVOLU_MOVEM R18_ABNORMALITI_GAIT_MOBIL R18_OTHER_LACK_COORD R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS	35255
6. Filter based on genotype QC (FinnGen only)	31909

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R
Name in latin: Symptomata et signa ad systema nervosum et systema musculosceletale pertinentia

NAME	R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	R18_ABNORMAL_INVOLU_MOVEM\|R18_ABNORMALITI_GAIT_MOBIL\|R18_OTHER_LACK_COORD\|R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R2[5-9]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R2[5-9]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Symptoms and signs involving the nervous and musculoskeletal systems based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	31909	18676	13233
Unadjusted period prevalence (%)	6.40	6.63	6.07
Median age at first event (years)	57.43	53.45	63.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
32857: Matched controls
328386

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S18

ICPC

Laceration/cut

1.6

321.7

15234

117102

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

321.6

2537

11336

R13

ICD-10 Finland

Dysphagia

2.3

320.6

2560

11498

N03AX11

ATC

topiramate; oral

3.7

319.9

1043

2880

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

319.8

13943

105156

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.4

319.0

2475

10978

B01AC04

ATC

clopidogrel; oral

1.8

315.6

5276

31008

XA402

NOMESCO Finland

ENMG

3.7

315.3

1046

2922

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

315.0

2262

9691

N02BF02

ATC

pregabalin; oral

2.3

311.2

2530

11446

R11

ICD-10 Finland

Nausea and vomiting

2.1

309.5

3193

15900

P20

ICPC

Memory disturbance

1.9

309.4

4630

26264

N02BF01

ATC

gabapentin; oral

2.4

307.7

4250

18889

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

4.4

307.7

1431

3383

G72.9

ICD-10 Finland

Myopathy, unspecified

8.2

307.7

490

602

M79.7

ICD-10 Finland

Fibromyalgia

3.5

307.7

1568

4668

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

307.7

13258

87379

H02AB06

ATC

prednisolone; systemic

1.6

307.7

15409

117618

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

307.7

10434

71484

N06AB10

ATC

escitalopram; oral

1.9

307.7

7034

42105

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

307.7

10162

68382

N02AX02

ATC

tramadol; systemic, rectal

1.8

307.7

14598

102237

M03BX01

ATC

baclofen; systemic

4.8

307.7

922

1953

R42

ICD-10 Finland

Dizziness and giddiness

2.4

307.7

9824

49396

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.1

307.7

2939

7721

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

307.7

2776

9446

G44.2

ICD-10 Finland

Tension-type headache

2.3

307.7

5409

26052

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

10275

71588

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

16.0

307.7

318

200

A02BC05

ATC

esomeprazole; systemic

1.6

307.7

12991

95513

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

307.7

2317

9570

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

307.7

6582

37228

N03AF01

ATC

carbamazepine; oral, rectal

2.8

307.7

1865

6979

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

307.7

9952

62132

R55

ICD-10 Finland

Syncope and collapse

2.2

307.7

4256

20438

G25.0

ICD-10 Finland

Essential tremor

4.4

307.7

1321

3126

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

307.7

5728

31489

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

307.7

6402

36470

N03AX12

ATC

[U] gabapentin; oral

2.9

307.7

7392

29428

R1250

NOMESCO Finland

Evaluation of functional capability

4.5

307.7

1293

2993

Z00.0

ICD-10 Finland

General medical examination

2.0

307.7

7290

40248

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

8.1

307.7

756

953

R25.3

ICD-10 Finland

Fasciculation

32.4

307.7

526

165

Z2445

NOMESCO Finland

Psychologist

3.4

307.7

1718

5206

N87

ICPC

Parkinsonism

4.8

307.7

758

1596

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

307.7

2678

12047

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

307.7

3437

17189

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.7

307.7

3157

9070

AA1AD

NOMESCO Finland

CT of head and brain

2.6

307.7

12304

62011

M03BX02

ATC

tizanidine; oral

1.6

307.7

19514

158315

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

31.5

307.7

519

167

SPAT1301

SPAT

No procedures

1.7

307.7

10590

70917

N06AX21

ATC

duloxetine; oral

2.9

307.7

5478

21315

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

307.7

4187

15756

SPAT1240

SPAT

Therapeutic discussion

2.1

307.7

3676

18242

TAB00

NOMESCO Finland

Lumbar puncture

5.5

307.7

2842

5555

A02BC02

ATC

pantoprazole; systemic

1.8

307.7

22608

182600

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

307.7

3898

19133

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.9

307.7

867

1791

R06.0

ICD-10 Finland

Dyspnoea

1.8

307.7

9551

60226

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.4

307.7

2321

7200

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.0

307.7

1594

4175

N03AX16

ATC

[U] pregabalin

2.3

307.7

9152

46450

R26.0

ICD-10 Finland

Ataxic gait

83.6

307.7

372

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

49.9

307.7

419

SPAT1216

SPAT

Assessment of functional ability

2.2

307.7

5853

29144

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

6.7

307.7

599

906

G35

ICD-10 Finland

Multiple sclerosis

4.9

307.7

770

1593

C07AA05

ATC

propranolol; systemic

2.2

307.7

7565

40030

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

307.7

8172

49390

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.8

307.7

5180

15356

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

307.7

6117

36290

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

307.7

15574

117345

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

6.4

307.7

700

1110

G20

ICD-10 Finland

Parkinson disease

5.0

307.7

1742

3663

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.5

307.7

1353

4035

R52.9

ICD-10 Finland

Pain, unspecified

2.0

307.7

3804

19744

R25.1

ICD-10 Finland

Tremor, unspecified

21.9

307.7

4036

2090

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.3

307.7

4166

13729

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

307.7

13091

92358

R20.2

ICD-10 Finland

Paraesthesia of skin

3.3

307.7

3555

11580

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

307.7

2646

11897

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

307.7

2952

13657

R53

ICD-10 Finland

Malaise and fatigue

2.3

307.7

10456

56140

SPAT1263

SPAT

Sampling

1.7

307.7

13834

100368

N03AE01

ATC

clonazepam; systemic

4.2

307.7

3012

7642

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

5.6

307.7

651

1173

M79.1

ICD-10 Finland

Myalgia

1.9

307.7

5131

29657

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

307.7

10573

60575

N06AB04

ATC

citalopram; systemic

2.0

307.7

7262

41414

N02BE01

ATC

paracetamol; systemic, rectal

2.1

307.7

29349

262075

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

13093

86005

S06.0

ICD-10 Finland

Concussion

2.2

307.7

4062

19917

N28

ICPC

Limited function/disability (N)

4.9

307.7

880

1837

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

307.7

2664

11554

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

307.7

3575

16974

N04BC05

ATC

pramipexole; oral

2.5

307.7

2901

12165

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.2

307.7

1751

4382

N06AX16

ATC

venlafaxine; oral

2.4

307.7

5628

26345

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.3

307.7

1389

4286

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

307.7

4252

17698

SPAT1229

SPAT

Assessment of need for aid

2.6

307.7

2945

12129

N05BA04

ATC

oxazepam; oral

1.9

307.7

9424

56474

M48.0

ICD-10 Finland

Spinal stenosis

2.3

307.7

4690

22278

N99

ICPC

Neurological disease other

6.0

307.7

687

1170

N06AX11

ATC

mirtazapine; oral

1.9

307.7

12418

78171

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

549.4

307.7

22163

1234

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

307.7

9656

64898

L03

ICPC

Low back symptom/complaint

1.7

307.7

10030

66638

N03AG01

ATC

valproic acid; systemic, rectal

3.3

307.7

2738

8694

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

82.0

307.7

1823

235

N05AH04

ATC

quetiapine; oral

2.4

307.7

7102

34314

SPAT1252

SPAT

Overall medication plan or its review

2.5

307.7

2468

10529

Z71.8

ICD-10 Finland

Other specified counselling

1.7

307.7

11675

81336

P29

ICPC

Psychological sympt/compl other

2.3

307.7

2800

12614

N05BA01

ATC

diazepam; systemic, rectal

2.2

307.7

4737

23077

N03AX09

ATC

lamotrigine; oral

3.6

307.7

2258

6600

R27.0

ICD-10 Finland

Ataxia, unspecified

97.9

307.7

606

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.5

307.7

1225

2785

N03AF02

ATC

oxcarbazepine; oral

3.9

307.7

1563

4171

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

307.7

5006

24019

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

8985

59820

A28

ICPC

Limited function/disability NOS

2.0

307.7

6412

35295

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

307.7

5433

25725

N17

ICPC

Vertigo/dizziness

1.9

307.7

4532

25161

N29

ICPC

Neurological sympt/complt other

4.1

307.7

917

2282

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

307.7

5207

26996

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

307.7

4462

18593

L28

ICPC

Limited function/disability (L)

2.4

307.7

7927

38160

R51.80

ICD-10 Finland

Headache

2.7

307.7

7159

30299

C07AB07

ATC

bisoprolol; oral

1.6

307.7

15278

116846

N06AA09

ATC

amitriptyline; systemic

2.4

307.7

3530

15587

R52.2

ICD-10 Finland

Other chronic pain

3.7

307.7

1807

5081

R25.2

ICD-10 Finland

Cramp and spasm

11.3

307.7

2429

2308

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

307.7

2694

11986

N05CF01

ATC

zopiclone; oral

1.7

307.7

10418

71134

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

99.2

307.7

3610

408

N05AH03

ATC

olanzapine; systemic

2.6

307.7

2344

9528

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.6

307.7

3166

12960

A04

ICPC

Weakness/tiredness general

1.9

307.7

5964

33552

SPAT1254

SPAT

Administration of medicine

2.0

307.7

5251

29113

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

5.2

307.7

2125

4296

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

307.7

5310

28557

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

307.7

3040

14049

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

15703

107796

R4110, ,

SPAT

2.0

307.7

4791

26314

NXL00

NOMESCO Finland

Biopsy of muscle

15.2

307.7

301

199

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.0

307.7

2193

7609

N06AB06

ATC

sertraline; oral

2.1

307.7

3958

20555

L17

ICPC

Foot/toe symptom/complaint

1.6

307.7

10340

71767

RD211, ,

NOMESCO Finland

3.5

307.7

1919

5651

A01

ICPC

Pain general/multiple sites

2.1

307.7

3770

18849

R29.2

ICD-10 Finland

Abnormal reflex

60.9

307.7

206

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

307.7

2520

10351

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

17746

140167

XA800

NOMESCO Finland

Neuropsychological investigation

4.3

307.7

2271

5627

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

307.7

7975

51748

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.8

307.2

1592

5809

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

306.4

6323

39499

N05AX08

ATC

risperidone; systemic

2.2

305.8

2934

14203

R02

ICPC

Shortness of breath/dyspnoea

1.9

301.1

4785

27647

-1, ,

NOMESCO Finland

1.6

296.5

10444

74664

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.4

295.6

2288

10126

A02BC03

ATC

lansoprazole; oral

1.6

293.4

8893

61316

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

293.2

6004

37371

L01

ICPC

Neck symptom/complaint

1.8

292.7

5515

33519

RF420, ,

NOMESCO Finland

5.0

292.5

635

1285

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

292.1

2305

10286

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

292.0

4224

23666

N05AX12

ATC

aripiprazole; systemic

2.8

291.0

1487

5383

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

290.7

3372

17515

SPAT1153

SPAT

Removal of sutures

1.6

289.6

9759

68965

A02BC01

ATC

omeprazole; systemic

1.6

289.0

8648

59401

M25.5

ICD-10 Finland

Pain in joint

1.6

281.8

10482

75670

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

278.8

4237

24093

M54.2

ICD-10 Finland

Cervicalgia

2.1

275.9

2825

14000

R5110, ,

SPAT

2.1

275.2

3023

15379

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

273.1

22853

195547

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.8

272.9

501

871

HMAK, ,

NOMESCO Finland

1.9

270.6

3765

20792

G04BD12

ATC

mirabegron; oral

1.9

269.9

4001

22554

SPAT1097

SPAT

Recording of ECG

1.8

269.0

4612

27196

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

268.5

1705

6886

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

268.3

1958

8434

U04

ICPC

Incontinence urine

2.3

264.3

2088

9311

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

262.1

5992

38299

RF410, ,

NOMESCO Finland

5.1

261.6

554

1097

A06AD11

ATC

lactulose; oral

1.8

259.9

4613

27461

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

258.8

2454

11793

P03

ICPC

Feeling depressed

1.9

257.9

3411

18503

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

257.3

3396

18409

R07.3

ICD-10 Finland

Other chest pain

1.9

257.2

3503

19188

N06AB03

ATC

fluoxetine; oral

1.9

256.6

3911

22218

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

255.5

3114

16422

G24.9

ICD-10 Finland

Dystonia, unspecified

10.7

253.7

275

258

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

5.2

253.4

530

1038

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

252.5

14368

112752

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.5

252.4

908

2673

N03AX14

ATC

levetiracetam; systemic

3.0

252.1

1146

3885

N02AA05

ATC

oxycodone; systemic

1.7

250.3

5760

36828

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

250.0

3365

18351

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

249.9

8259

57715

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

249.0

5989

38728

RF120, ,

NOMESCO Finland

5.1

248.9

528

1047

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

246.0

8104

56553

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

245.0

17130

139669

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.5

244.8

862

2502

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

243.7

9245

66557

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.1

243.5

1055

3479

A29

ICPC

General symptom/complaint other

1.8

243.3

4497

27045

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.3

241.9

1923

8590

N06AX26

ATC

vortioxetine; oral

2.1

241.5

2602

13116

G25.2

ICD-10 Finland

Other specified forms of tremor

7.1

241.2

363

515

SPAT1053

SPAT

Memory test

1.8

238.8

4314

25761

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

238.1

13385

104375

SPAT1131

SPAT

Colonoscopy

2.9

233.5

1138

4009

H53.2

ICD-10 Finland

Diplopia

2.8

233.3

1192

4308

G47.3

ICD-10 Finland

Sleep apnoea

1.6

232.7

7029

47976

N04BD01

ATC

selegiline; oral

4.3

231.7

601

1405

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

230.2

6769

45893

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

230.0

1976

9113

R50.9

ICD-10 Finland

Fever, unspecified

1.7

229.4

4951

31044

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

229.2

3529

20066

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

229.0

1473

5978

P01

ICPC

Feeling anxious/nervous/tense

1.8

228.6

4080

24254

J01DB01

ATC

cefalexin; oral

1.6

228.2

26383

236342

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.4

228.0

1588

6687

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

225.5

2525

12896

N05AA02

ATC

levomepromazine; systemic

2.6

224.7

1320

5125

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.6

224.4

1414

5681

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.1

224.0

959

3139

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

224.0

10681

80346

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

222.4

2737

14452

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

222.2

2576

13319

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

221.7

1046

3619

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.5

221.4

363

564

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

220.6

7220

50107

P76

ICPC

Depressive disorder

2.1

220.3

2247

11084

N30.0

ICD-10 Finland

Acute cystitis

1.6

220.2

5591

36527

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.1

220.1

940

3072

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

220.1

7191

49882

G43.3

ICD-10 Finland

Complicated migraine

3.7

219.9

705

1922

R60.0

ICD-10 Finland

Localized oedema

1.8

219.6

4105

24709

N01

ICPC

Headache

1.8

219.2

3732

21860

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.6

219.1

525

1153

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.9

217.5

1042

3635

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

217.0

12882

100940

UJF32

NOMESCO Finland

Coloscopy

1.5

217.0

8042

57330

L29

ICPC

Musculoskeletal sympt/complt other

1.9

216.5

3001

16485

UKC02

NOMESCO Finland

Cystoscopy

1.7

216.4

4911

31160

KMAK, ,

NOMESCO Finland

1.4

214.9

15278

123716

R35

ICD-10 Finland

Polyuria

2.1

213.3

2301

11586

R27.8

ICD-10 Finland

Other and unspecified lack of coordination

56.8

211.5

119

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

211.1

5117

33003

A02BA02

ATC

ranitidine; systemic

1.6

210.4

5627

37187

R26

ICD-10 Finland

Abnormalities of gait and mobility

14.0

210.2

193

139

G54.0

ICD-10 Finland

Brachial plexus disorders

3.0

209.7

934

3127

N06AX12

ATC

bupropion; oral

2.0

208.5

2315

11776

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

208.1

22463

195847

R25.0

ICD-10 Finland

Abnormal head movements

91.1

208.0

109

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

207.8

1130

4217

C03CA01

ATC

furosemide; systemic

1.5

207.6

8949

65735

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

206.8

6026

40631

G12.2

ICD-10 Finland

Motor neuron disease

7.5

205.1

294

395

SPAT1260

SPAT

Consultation of another employee

1.6

202.8

5464

36139

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.4

202.2

740

2201

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

201.1

2088

10357

SPAT1359

SPAT

Use of symptom diary

3.0

200.7

926

3163

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

200.4

7684

55018

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

198.5

12330

96945

N18

ICPC

Paralysis/weakness

3.3

198.4

753

2291

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.4

197.8

1377

5791

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

197.4

3726

22443

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

197.1

11901

93054

K02.1

ICD-10 Finland

Caries of dentine

1.4

196.8

18183

153270

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.8

196.8

449

947

N05CD07

ATC

temazepam; oral

1.8

196.8

3424

20145

M54.1

ICD-10 Finland

Radiculopathy

2.4

195.8

1363

5732

R1250, ,

SPAT

2.6

195.0

1160

4528

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

194.3

1461

6358

N05AN01

ATC

lithium; oral

3.1

193.8

850

2820

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

193.4

3363

19778

SPAT1234

SPAT

Support of social functional capacity

2.2

192.7

1681

7788

N04BC04

ATC

ropinirole; oral

4.5

190.8

469

1051

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.4

189.6

695

2069

F44.4

ICD-10 Finland

Dissociative motor disorders

27.3

188.5

128

N05BA12

ATC

alprazolam; oral

1.8

188.4

2967

16932

R05

ICPC

Cough

1.5

188.2

7843

57000

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.3

188.1

726

2232

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

187.3

3999

24888

Z08

ICPC

Social welfare problem

3.9

187.2

552

1419

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

186.3

10753

83155

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

186.1

1186

4785

N06AX03

ATC

mianserin; oral

2.3

184.1

1513

6837

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

183.2

3943

24581

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

182.6

12815

102494

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

182.5

1904

9452

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.6

182.0

1124

4467

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

181.5

1842

9050

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.8

181.0

932

3378

183

Kela drug reimbursment

Lamotrigin and topiramate

4.9

181.0

403

833

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

180.4

1302

5562

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

179.9

20679

179604

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.6

179.8

1045

4031

SFA10

NOMESCO Finland

One-surface restoration

1.4

178.1

16809

141116

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

177.8

1049

4077

P99

ICPC

Psychological disorders other

2.6

177.6

1049

4079

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

5.7

177.2

331

585

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

176.7

4398

28437

EBA00

NOMESCO Finland

Extraction of tooth

1.4

176.7

11068

86644

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

175.9

7600

55506

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

175.9

5824

40245

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

175.6

3838

24005

J01MA02

ATC

ciprofloxacin; systemic

1.4

173.6

11564

91425

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

173.3

1383

6171

N04AA02

ATC

biperiden; systemic

3.3

173.3

664

2032

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

172.3

3690

22950

L12

ICPC

Hand/finger symptom/complaint

1.6

172.0

5387

36748

RF210, ,

NOMESCO Finland

2.7

171.3

938

3510

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.7

171.3

987

3790

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

170.6

2411

13284

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.3

169.9

668

2077

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

169.6

3022

17861

109

Kela drug reimbursment

Multiple sclerosis

4.2

169.5

461

1117

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

8.4

168.2

218

260

D01

ICPC

Abdominal pain/cramps general

1.6

168.1

3931

25000

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

167.9

5389

36940

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

167.2

2992

17702

J01AA02

ATC

doxycycline; systemic

1.4

167.1

23723

212117

R03DC03

ATC

montelukast; oral

1.6

167.0

4936

33210

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

166.0

4044

25977

WZC30

NOMESCO Finland

Teaching

1.6

164.6

4971

33599

K30

ICD-10 Finland

Functional dyspepsia

1.7

163.9

3528

21951

R29.4

ICD-10 Finland

Clicking hip

20.2

163.9

125

M01AH01

ATC

celecoxib; oral

1.5

162.8

5177

35386

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.4

162.7

1137

4785

R00.2

ICD-10 Finland

Palpitations

1.8

162.4

2508

14200

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.4

162.3

602

1805

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

4.4

162.3

410

939

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

162.2

2542

14457

J01EA01

ATC

trimethoprim; systemic

1.5

162.0

7599

56241

R52.1

ICD-10 Finland

Chronic intractable pain

4.5

161.7

399

897

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

161.6

1072

4405

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

161.3

1567

7565

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

160.2

7420

54761

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.7

160.2

377

816

SPAT1312

SPAT

General health counselling

1.4

159.7

9439

72828

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

159.5

4113

26771

XKD00

NOMESCO Finland

Uroflowmetry

1.6

158.6

4463

29656

XKC03

NOMESCO Finland

Water cystometry

2.5

158.0

996

3995

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

157.8

3082

18672

L08

ICPC

Shoulder symptom/complaint

1.5

157.4

6897

50336

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

155.6

3115

18995

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

4.0

154.4

449

1143

M01AC06

ATC

meloxicam; systemic, rectal

1.4

154.0

10248

80575

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

153.2

1305

5979

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

153.1

4012

26196

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

4.4

153.0

383

871

N06AB05

ATC

paroxetine; oral

2.0

151.9

1774

9159

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

151.9

1459

7011

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.0

151.7

706

2421

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.1

151.6

649

2122

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.2

151.6

627

2009

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.5

151.3

986

4017

P06

ICPC

Sleep disturbance

1.6

150.4

3919

25547

R5599

NOMESCO Finland

Other rehabilitation service

2.6

150.2

912

3592

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

150.2

3020

18428

P01AB01

ATC

metronidazole; oral, rectal

1.4

149.9

11732

94608

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.4

149.9

1075

4575

SPAT1262

SPAT

Handing over of treatment supplies

1.5

149.6

4981

34325

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

149.4

5024

34696

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.6

149.0

492

1368

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

148.9

9802

76824

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

148.9

1262

5769

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.5

148.7

511

1459

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

148.4

5706

40515

R06AE07

ATC

cetirizine; oral

1.4

148.3

13034

106993

R51.81

ICD-10 Finland

Facial pain NOS

2.7

148.0

822

3097

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

148.0

1512

7436

N05AF03

ATC

chlorprothixene; systemic

2.7

148.0

828

3132

R33

ICD-10 Finland

Retention of urine

1.8

147.9

2339

13324

K07.60

ICD-10 Finland

Snapping jaw

2.0

147.8

1603

8059

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

6.8

147.6

231

342

PA6AD

NOMESCO Finland

CT of neck arteries

2.3

147.4

1219

5516

RS340, ,

NOMESCO Finland

10.2

146.9

165

163

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

146.8

774

2839

Z00.8

ICD-10 Finland

Other general examinations

1.8

146.5

2513

14663

U02

ICPC

Urinary frequency/urgency

1.5

146.2

4529

30707

C10AA01

ATC

simvastatin; oral

1.4

145.8

11616

93821

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

145.7

3525

22554

C07AB02

ATC

metoprolol; systemic

1.5

145.4

5597

39732

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.7

144.7

804

3030

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

144.4

11209

90126

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.0

143.8

413

1042

SPAT1360

SPAT

Extensive global examination

1.8

143.2

2120

11830

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.3

143.1

1096

4800

F34.1

ICD-10 Finland

Dysthymia

2.3

143.1

1139

5071

H13

ICPC

Plugged feeling ear

1.5

143.0

5766

41294

R03BA01

ATC

beclometasone; inhalant

1.6

142.8

4021

26669

R4120

NOMESCO Finland

Occupational therapy

1.9

142.7

1989

10889

A11

ICPC

Chest pain NOS

1.7

142.5

2623

15610

ZY010

NOMESCO Finland

Hospital outpatient

2.0

142.4

1574

7965

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.3

141.8

1162

5237

SFA20

NOMESCO Finland

Two-surface restoration

1.3

141.7

17442

150236

N05CF02

ATC

zolpidem; oral

1.5

141.5

4960

34517

SPAT1050

SPAT

Extensive neurological examination

2.8

140.8

718

2588

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

140.7

1343

6434

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

140.3

4122

27596

L02

ICPC

Back symptom/complaint

1.7

140.1

3149

19766

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

139.9

2747

16640

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

139.7

3202

20197

G40.10

ICD-10 Finland

Simple partial seizures

4.8

139.7

316

662

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.5

138.9

915

3745

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

138.8

3925

26044

J01FF01

ATC

clindamycin; systemic

1.4

137.3

7783

59301

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.9

137.0

656

2285

N05AB03

ATC

perphenazine; systemic, rectal

2.3

136.7

1025

4448

A03

ICPC

Fever

1.5

136.5

5187

36671

RK112, ,

NOMESCO Finland

15.4

135.6

118

J02AC01

ATC

fluconazole; systemic

1.4

135.3

11354

92144

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

135.2

2075

11703

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

6.7

135.1

215

324

E0000UV, ,

ATC

1.3

135.0

12497

102928

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.8

135.0

411

1081

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

134.9

8965

70116

H03AA01

ATC

levothyroxine sodium; systemic

1.4

134.9

6662

49510

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.0

134.7

1503

7628

WX290

NOMESCO Finland

Other blockage of nerve

1.3

134.7

13849

115833

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.4

134.1

492

1465

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

133.9

2798

17222

R96

ICPC

Asthma

1.7

133.9

2988

18710

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

7.1

133.7

200

282

M01AE02

ATC

naproxen; oral, rectal

1.3

133.3

16713

143772

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.6

133.0

781

3025

K90

ICPC

Stroke/cerebrovascular accident

2.4

132.9

908

3779

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

132.9

1345

6587

L13

ICPC

Hip symptom/complaint

1.5

132.9

5676

41039

Z3226

NOMESCO Finland

Physiotherapist

1.5

132.7

5131

36381

M01AH05

ATC

etoricoxib; oral

1.3

132.4

18357

160140

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.6

132.3

776

3004

XCK00

NOMESCO Finland

Perimetry

1.9

131.4

1831

10016

J45.8

ICD-10 Finland

Mixed asthma

2.4

131.4

966

4155

L14

ICPC

Leg/thigh symptom/complaint

1.7

131.3

2512

15098

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

131.2

4679

32624

H57.1

ICD-10 Finland

Ocular pain

2.1

130.9

1241

5928

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.4

130.8

475

1405

WZC00, ,

SPAT

1.5

130.5

4525

31363

N27

ICPC

Fear of neurological disease other

3.0

130.1

603

2063

N86

ICPC

Multiple sclerosis

4.9

130.1

286

585

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

129.2

1590

8348

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

129.2

557

1829

R03BA05

ATC

fluticasone; inhalant

1.5

128.7

5272

37781

S22.3

ICD-10 Finland

Fracture of rib

1.8

128.7

2122

12222

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

128.3

1042

4677

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

128.0

2717

16786

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

127.8

1063

4818

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

127.7

1692

9104

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.1

127.4

1253

6069

L86

ICPC

Back syndrome with radiating pain

1.8

127.3

1893

10566

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

127.2

3985

27016

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

126.7

3501

23073

G04CA02

ATC

tamsulosin; oral

1.4

126.7

6347

47214

G43.8

ICD-10 Finland

Other migraine

3.1

126.5

536

1742

W19

ICD-10 Finland

Unspecified fall

1.6

126.3

2956

18718

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

4.0

126.3

368

938

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

126.1

2539

15466

SFA30

NOMESCO Finland

Three-surface restoration

1.3

125.6

12180

100674

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

125.4

3839

25887

EB1VA, ,

NOMESCO Finland

1.5

125.4

5266

37900

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

124.9

3073

19697

N06AX22

ATC

agomelatine; oral

2.6

124.8

750

2938

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.3

124.8

930

4024

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

124.7

1406

7160

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

124.7

1878

10524

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

8.0

124.6

169

213

X58

ICD-10 Finland

Exposure to other specified factors

1.5

123.8

4295

29746

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.3

123.7

956

4201

N06AA10

ATC

nortriptyline; systemic

2.7

123.6

668

2482

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.5

123.3

788

3179

R21

ICPC

Throat symptom/complaint

1.4

123.0

6247

46550

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

122.8

6381

47737

XCH00

NOMESCO Finland

Eye pressure measurement

2.0

122.7

1452

7519

A05

ICPC

Feeling ill

1.8

122.4

1862

10465

N06AA12

ATC

doxepin; systemic

2.0

122.1

1436

7420

N03AX18

ATC

lacosamide; systemic

4.2

122.1

329

792

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

6.6

121.8

196

299

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

121.7

17742

154985

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

121.3

1409

7250

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

121.1

4036

27704

G04BD08

ATC

solifenacin; oral

1.8

121.1

1884

10658

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

120.6

2974

19067

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

120.2

2020

11692

S29

ICPC

Skin symptom/complaint other

1.4

119.8

6110

45537

C08CA01

ATC

amlodipine; oral

1.3

119.7

10891

89009

ZXY02

NOMESCO Finland

Neuropsychologist

5.3

119.7

240

453

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

119.6

583

2051

Z11

ICPC

Compliance/being ill problem

4.4

119.5

300

684

C10AA05

ATC

atorvastatin; oral

1.3

119.5

11966

99147

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

119.0

3831

26096

S15

ICPC

Foreign body in skin

1.8

118.2

1953

11247

PEN23

NOMESCO Finland

Plastic repair of femoral artery

4.0

118.2

337

846

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

3.4

117.2

420

1232

U05

ICPC

Urination problems other

1.9

117.2

1587

8596

M01AB05

ATC

diclofenac; systemic, rectal

1.3

117.2

19345

171442

L16

ICPC

Ankle symptom/complaint

1.5

117.1

3538

23766

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

117.0

4782

34189

H01

ICPC

Ear pain/earache

1.5

117.0

3547

23844

UDC00

NOMESCO Finland

Ear microscopy

1.7

116.3

2167

12914

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.1

116.2

324

800

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

116.1

6155

46149

L19

ICPC

Muscle symptom/complaint NOS

2.3

115.8

943

4236

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

14.7

115.8

103

U01

ICPC

Dysuria/painful urination

1.7

114.9

2371

14521

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

114.9

7613

59219

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.8

114.6

573

2043

R47.1

ICD-10 Finland

Dysarthria and anarthria

4.0

114.5

333

848

R51

ICD-10 Finland

Headache

1.8

114.4

1694

9436

J01FA06

ATC

roxithromycin; oral

1.3

114.3

11111

91512

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

114.2

1684

9368

N04BD02

ATC

rasagiline; oral

4.3

114.1

295

688

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

114.0

1590

8692

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

113.9

1726

9684

Z01.2

ICD-10 Finland

Dental examination

1.3

113.9

13874

117849

AN1

Coronary angiography

1.6

113.8

2925

18924

J01CA04

ATC

amoxicillin; systemic

1.4

113.4

25276

233150

R01AD09

ATC

mometasone; nasal

1.3

113.1

13130

110769

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

113.1

1586

8685

N05BA09

ATC

clobazam; oral

4.7

113.1

263

564

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

113.0

3754

25723

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.1

112.9

1060

5041

UJD02

NOMESCO Finland

Gastroscopy

2.0

112.9

1373

7174

N05BE01

ATC

buspirone; oral

2.3

112.6

860

3759

R06.4

ICD-10 Finland

Hyperventilation

2.9

112.6

528

1818

G50.1

ICD-10 Finland

Atypical facial pain

2.8

112.5

589

2152

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

112.3

1762

9990

M54.3

ICD-10 Finland

Sciatica

1.8

112.0

1726

9731

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

112.0

11967

99779

D07AC01

ATC

betamethasone; topical

1.3

111.8

10506

86039

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

111.8

1868

10788

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

6.2

111.8

192

313

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

12.6

111.7

109

SPAT1243

SPAT

Psychiatric/psychological examination

2.4

111.6

782

3291

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

111.5

7457

58045

H46

ICD-10 Finland

Optic neuritis

4.0

111.5

319

803

G44.0

ICD-10 Finland

Cluster headache syndrome

3.5

111.4

388

1118

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

111.3

3774

25968

M01AX17

ATC

nimesulide; oral

1.4

111.1

6387

48502

F45.0

ICD-10 Finland

Somatization disorder

5.7

111.0

206

362

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

110.7

579

2115

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

110.4

15437

133334

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.0

110.2

1163

5779

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

5.1

110.1

234

465

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

110.1

7261

56370

C10AX09

ATC

ezetimibe; oral

1.5

109.9

4684

33721

M35.7

ICD-10 Finland

Hypermobility syndrome

3.1

109.8

470

1537

J01DA01

ATC

[U] cefalexin

1.3

109.6

17951

158206

G24.8

ICD-10 Finland

Other dystonia

6.8

109.4

170

250

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.9

109.2

517

1790

N07AA02

ATC

pyridostigmine; systemic

5.3

109.1

219

414

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.7

109.0

342

919

G24.3

ICD-10 Finland

Spasmodic torticollis

3.7

108.9

354

974

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.2

108.9

982

4597

G82.2

ICD-10 Finland

Paraplegia, unspecified

5.7

108.8

201

352

J01FA10

ATC

azithromycin; systemic

1.3

108.7

16712

146009

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

3.6

108.7

367

1036

IHZ05, ,

SPAT

2.0

108.6

1312

6839

J01CA08

ATC

pivmecillinam; oral

1.3

108.4

11503

95698

S01

ICPC

Pain/tenderness of skin

1.9

108.1

1429

7676

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.5

108.0

383

1116

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

107.8

7549

59127

K59.0

ICD-10 Finland

Constipation

1.8

107.5

1686

9553

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.1

107.4

292

708

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.8

107.3

329

870

K05

ICPC

Irregular heartbeat other

2.2

106.6

982

4636

M89.0

ICD-10 Finland

Algoneurodystrophy

3.9

106.4

318

826

P74

ICPC

Anxiety disorder/anxiety state

1.9

106.1

1318

6934

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

105.9

855

3826

PLAK1, ,

NOMESCO Finland

3.5

105.8

369

1064

R01AD01

ATC

beclometasone; nasal

1.5

105.8

4113

29071

AA5PD

NOMESCO Finland

CT examination of brain pefusion

3.6

105.4

353

991

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

105.4

2535

16127

D11

ICPC

Diarrhoea

1.5

105.1

3473

23748

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

104.9

6665

51374

G61.0

ICD-10 Finland

Guillain-Barré syndrome

6.4

104.5

174

275

R5120

NOMESCO Finland

Preparation of an aid

2.2

104.1

862

3899

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

103.9

2619

16851

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

103.7

1954

11669

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

103.7

3031

20179

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

103.3

877

4007

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.9

103.1

504

1776

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

102.9

1247

6506

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

102.8

3135

21064

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.9

102.5

505

1787

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

102.4

14679

126708

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

102.2

3384

23141

U07

ICPC

Urine symptom/complaint other

1.6

102.1

2504

16000

M54.8

ICD-10 Finland

Other dorsalgia

1.9

102.1

1371

7400

L03AX13

ATC

glatiramer acetate; parenteral

5.5

102.0

198

363

SPAT1255

SPAT

Intravenous administration of medicine

1.7

102.0

1876

11127

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

101.9

1285

6795

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

101.5

1737

10095

RS221, ,

NOMESCO Finland

3.0

101.4

467

1592

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

101.3

1355

7305

R06.5

ICD-10 Finland

Mouth breathing

1.6

101.1

2463

15712

N06AG02

ATC

moclobemide; oral

2.0

101.0

1194

6175

R01AD12

ATC

fluticasone furoate; nasal

1.3

100.6

8836

71423

R05

ICD-10 Finland

Cough

1.4

100.5

6186

47398

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

100.2

6236

47861

ZXE00

NOMESCO Finland

One hour or less

1.3

100.0

10930

91010

M02AA07

ATC

piroxicam; topical

1.3

100.0

9724

79709

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

99.9

932

4420

N07BB01

ATC

disulfiram; oral

2.0

99.4

1136

5807

Z03

ICPC

Housing/neighbourhood problem

4.3

99.3

255

592

R03BB04

ATC

tiotropium bromide; inhalant

1.6

99.3

2735

17957

L04

ICPC

Chest symptom/complaint

1.7

99.2

1869

11157

RS130, ,

NOMESCO Finland

8.7

99.2

125

144

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.9

99.0

217

443

A03FA02

ATC

cisapride; oral, rectal

1.7

98.8

2007

12225

R01AD08

ATC

fluticasone; nasal

1.3

98.2

7888

62907

J46

ICD-10 Finland

Status asthmaticus

2.2

97.9

862

3996

RS314, ,

NOMESCO Finland

8.8

97.7

122

139

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

97.6

1313

7090

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

97.4

6234

48030

S01.0

ICD-10 Finland

Open wound of scalp

1.6

97.3

2197

13750

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

97.2

7799

62174

D06

ICPC

Abdominal pain localized other

1.6

97.0

2649

17351

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

96.8

2143

13347

M01AH02

ATC

rofecoxib; oral

1.5

96.5

3337

23006

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.1

96.2

944

4565

L15

ICPC

Knee symptom/complaint

1.3

96.0

7188

56705

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.6

95.9

324

915

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.7

95.9

306

832

N06BA04

ATC

methylphenidate; oral

2.1

95.7

957

4660

SPAT1059

SPAT

Spirometry at the office

1.8

95.6

1383

7641

G72.8

ICD-10 Finland

Other specified myopathies

2.8

95.4

502

1839

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

95.4

1908

11573

K04

ICPC

Palpitations/awareness of heart

1.8

95.3

1547

8849

XF404

NOMESCO Finland

Ambulatory ECG

1.6

95.2

2345

14990

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

94.8

2087

12975

R29.3

ICD-10 Finland

Abnormal posture

25.4

94.6

N08

ICPC

Abnormal involuntary movements

6.1

94.6

164

270

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

94.6

970

4768

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

94.6

4139

29869

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

94.5

1342

7371

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.5

94.4

584

2320

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.3

94.4

711

3089

K29

ICPC

Cardiovascular sympt/complt other

1.9

94.3

1276

6901

SPAT1101

SPAT

Orthostatic test

1.9

93.8

1167

6140

A02BC04

ATC

rabeprazole; oral

1.6

93.7

2386

15374

SPAT1325

SPAT

Vaccination

1.3

93.4

9332

76607

R25

ICD-10 Finland

Abnormal involuntary movements

24.5

93.3

D12

ICPC

Constipation

1.9

93.2

1133

5914

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.5

92.9

601

2438

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

92.8

1363

7565

SGA01

NOMESCO Finland

Emergency treatment

1.4

92.8

4412

32312

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

92.7

10047

83347

R12

ICD-10 Finland

Heartburn

1.6

92.7

2403

15545

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.8

92.6

460

1635

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

92.6

8291

67042

R29

ICPC

Respiratory symptom/complaint other

1.7

92.0

1959

12073

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

92.0

2920

19762

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

92.0

6013

46420

S70.0

ICD-10 Finland

Contusion of hip

1.9

92.0

1119

5843

N89

ICPC

Migraine

2.0

91.7

1022

5176

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

91.7

1154

6094

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

91.6

748

3363

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

91.3

739

3310

ZX120

NOMESCO Finland

Intravenous

1.6

91.3

2535

16659

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

91.3

2191

13915

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

11.3

91.2

C10AA07

ATC

rosuvastatin; oral

1.3

91.2

9246

75997

A27

ICPC

Fear of other disease NOS

1.8

91.0

1447

8225

K07

ICPC

Swollen ankles/oedema

1.8

91.0

1364

7617

G04BD07

ATC

tolterodine; oral

1.9

90.9

1270

6940

C01DA14

ATC

isosorbide mononitrate; oral

1.4

90.8

3995

28840

Z29

ICPC

Social problem NOS

2.3

90.5

675

2920

RJ630, ,

NOMESCO Finland

11.2

90.5

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.5

90.1

575

2318

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.3

89.8

730

3276

WZC30, ,

SPAT

1.6

89.4

2387

15542

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

89.3

2065

12994

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

89.0

636

2700

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.3

88.7

682

2990

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

88.6

635

2699

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

4.6

88.5

210

458

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.3

88.5

229

535

N05AD01

ATC

haloperidol; systemic

2.1

88.3

844

4040

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

87.9

3818

27485

SPAT1106

SPAT

Acupuncture

3.9

87.9

258

662

L03AB07

ATC

interferon beta-1a; parenteral

4.4

87.9

219

497

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.3

87.5

677

2975

N06AX05

ATC

trazodone; oral

2.3

87.5

705

3152

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.3

87.5

677

2976

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.1

87.4

365

1177

S80.0

ICD-10 Finland

Contusion of knee

1.6

87.4

2144

13684

C09CA06

ATC

candesartan; oral

1.3

87.0

6709

53032

F32.8

ICD-10 Finland

Other depressive episodes

2.6

87.0

495

1888

R06AX27

ATC

desloratadine; oral

1.3

86.9

7992

64747

K08.80

ICD-10 Finland

Toothache NOS

1.5

86.7

2513

16666

C08DA01

ATC

verapamil; systemic

1.9

86.4

1112

5915

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.7

86.4

1531

8977

N19

ICPC

Speech disorder

2.8

86.3

446

1619

L11

ICPC

Wrist symptom/complaint

1.5

86.3

2622

17568

RS142, ,

NOMESCO Finland

7.7

86.2

120

156

C01CA24

ATC

epinephrine; parenteral

1.7

86.2

1683

10136

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

86.0

893

4409

C08CA13

ATC

lercanidipine; oral

1.4

85.9

3914

28411

AN2

Balloon angioplasty, including several vessels

2.2

85.9

741

3407

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

85.8

1319

7420

G91.0

ICD-10 Finland

Communicating hydrocephalus

4.8

85.5

194

408

SPAT1211

SPAT

Application of soft bandage

1.6

85.5

2388

15706

A01AB09

ATC

miconazole; local oral

1.6

85.4

2278

14824

N88

ICPC

Epilepsy

4.0

85.3

246

623

N06AA06

ATC

trimipramine; systemic

2.3

85.2

653

2859

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

85.1

1828

11286

R4120, ,

SPAT

2.8

85.1

432

1554

G11.2

ICD-10 Finland

Late-onset cerebellar ataxia

14.3

85.0

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

84.8

2783

18954

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

4.0

84.7

242

609

Z2446

NOMESCO Finland

Social worker

1.7

84.7

1740

10621

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

84.6

1199

6579

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

84.5

1969

12407

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

84.2

2051

13065

KHV, ,

NOMESCO Finland

3.8

84.0

255

670

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.9

83.8

395

1365

ZXD05

NOMESCO Finland

Urgent procedure

1.3

83.7

8283

67697

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

6.5

83.6

135

207

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.9

83.6

389

1335

R07

ICPC

Sneezing/nasal congestion

1.7

83.5

1807

11177

R15

ICD-10 Finland

Faecal incontinence

2.1

83.1

810

3906

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

83.1

2053

13120

G25.3

ICD-10 Finland

Myoclonus

8.3

82.8

108

130

N06DA03

ATC

rivastigmine; oral, transdermal

1.9

82.6

1170

6419

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.8

82.5

411

1464

M02AA10

ATC

ketoprofen; topical

1.4

82.2

4225

31303

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.7

82.1

445

1656

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

81.9

7335

59123

K08.3

ICD-10 Finland

Retained dental root

1.6

81.9

2140

13856

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

7.2

81.7

120

166

R03BA08

ATC

ciclesonide; inhalant

1.5

81.7

2354

15584

N05AH02

ATC

clozapine; systemic

2.6

81.6

489

1913

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

81.6

1814

11295

K04.08

ICD-10 Finland

Other specified pulpit

1.6

81.5

2086

13440

R09

ICPC

Sinus symptom/complaint

1.6

81.4

2240

14675

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.9

81.4

1013

5329

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

80.7

7914

64549

RF220, ,

NOMESCO Finland

2.7

80.6

427

1571

SPAT1104

SPAT

Monitoring of emergency patient

1.7

80.4

1728

10666

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

80.3

1247

7036

SPAT1284

SPAT

Extensive health certificate

2.1

80.3

777

3737

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

79.9

1346

7777

N04BC09

ATC

rotigotine; transdermal

4.8

79.6

179

374

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.2

79.5

693

3199

SPAT1058

SPAT

PEF monitoring instruction

1.6

79.4

2132

13887

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

6.5

79.4

129

199

G04CA01

ATC

alfuzosin; oral

1.5

79.4

3074

21629

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

79.3

2969

20753

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

79.1

1894

12007

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

78.9

845

4218

A99

ICPC

Disease/condition unspecnature/site

1.5

78.8

2930

20449

B01AA03

ATC

warfarin; systemic

1.4

78.7

4787

36435

T90

ICPC

Diabetes non-insulin dependent

1.3

78.5

6566

52381

D02

ICPC

Abdominal pain epigastric

1.6

78.5

1761

10988

AA1AA

NOMESCO Finland

Head X-ray examination

3.6

78.0

261

733

F44.5

ICD-10 Finland

Dissociative convulsions

19.1

77.9

B01AB05

ATC

enoxaparin; parenteral

1.3

77.9

8659

71705

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

77.8

1338

7776

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

77.8

579

2503

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

77.4

547

2312

F41.00

ICD-10 Finland

Moderate panic disorder

2.6

77.3

452

1748

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

77.2

1546

9369

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.3

77.1

579

2512

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

76.9

686

3196

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

76.9

1779

11184

G44.8

ICD-10 Finland

Other specified headache syndromes

2.6

76.7

449

1737

193

Kela drug reimbursment

Rasagiline

4.1

76.5

213

526

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

76.5

7703

62961

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.1

76.4

323

1050

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.0

76.2

797

3945

H02AB09

ATC

hydrocortisone; systemic

2.2

76.1

681

3177

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.0

76.1

341

1146

SCA02

NOMESCO Finland

Preventive oral health care

1.5

76.1

2850

19915

DFF15

NOMESCO Finland

Speech audiometry

1.7

76.0

1323

7716

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.9

75.9

1005

5395

A02BA04

ATC

nizatidine; systemic

1.6

75.4

1884

12064

XQ848

NOMESCO Finland

Dermatological photography

2.0

75.3

844

4283

SPAT1283

SPAT

Restricted health certificate

1.4

75.2

4426

33489

D21

ICPC

Swallowing problem

2.6

75.1

455

1790

R4130

NOMESCO Finland

Speech therapy

2.1

74.8

734

3548

K80

ICPC

Cardiac arrhythmia NOS

1.5

74.8

2351

15848

J01DA09

ATC

[U] cefadroxil

1.3

74.8

7007

56709

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

7.3

74.6

109

150

R1420, ,

SPAT

3.9

74.5

220

567

R5140, ,

SPAT

2.7

74.4

419

1590

I95.9

ICD-10 Finland

Hypotension, unspecified

2.6

74.4

454

1793

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.4

74.3

521

2194

G41.9

ICD-10 Finland

Status epilepticus, unspecified

4.0

74.3

208

516

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.0

74.2

823

4160

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

6.1

74.2

128

210

WX308

NOMESCO Finland

Sacral anesthesy

4.9

74.0

161

327

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

8.1

73.9

123

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

73.9

2438

16599

D09

ICPC

Nausea

1.7

73.8

1312

7695

J01MA14

ATC

moxifloxacin; systemic

1.5

73.6

2325

15686

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

73.6

882

4580

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

8.8

73.6

105

H53.4

ICD-10 Finland

Visual field defects

2.3

73.3

594

2662

S21

ICPC

Skin texture symptom/complaint

1.4

73.2

4262

32180

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

73.2

1697

10671

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.5

73.0

483

1981

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.3

73.0

275

834

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

72.9

1581

9778

R52.0

ICD-10 Finland

Acute pain

1.9

72.8

925

4899

S97

ICPC

Chronic ulcer skin

1.6

72.6

1710

10793

R01AD58

ATC

fluticasone, combinations; nasal

1.3

72.6

6792

54923

N07CA01

ATC

betahistine; oral

1.6

72.6

1875

12098

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.0

72.6

317

1050

RP120, ,

NOMESCO Finland

26.3

72.5

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

3.8

72.5

221

583

R4110

NOMESCO Finland

Physiotherapy

1.3

72.4

7594

62316

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.4

72.4

522

2226

N06BA07

ATC

modafinil; oral

5.1

72.2

152

300

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.8

72.2

367

1322

G40

ICD-10 Finland

Epilepsy

3.2

71.9

292

927

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

71.8

4648

35672

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

71.8

825

4223

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

5.0

71.8

155

313

N07

ICPC

Convulsion/seizure

5.8

71.3

130

225

XF606

NOMESCO Finland

Ortostatic test

3.2

71.2

278

862

H81.3

ICD-10 Finland

Other peripheral vertigo

2.0

70.9

793

4021

Y96.9

ICD-10 Finland

Unspecified type of accident

2.3

70.9

547

2402

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

70.9

624

2893

I702, R262,

ICD-10 Finland

+∞

70.8

G40.89

ICD-10 Finland

Other epilepsy

4.4

70.8

177

403

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

70.5

2927

20839

ZY000

NOMESCO Finland

Hospital inpatient

2.7

70.4

373

1373

SFA00

NOMESCO Finland

Small restoration

1.4

70.4

3751

27905

IGY02, ,

SPAT

2.5

70.2

460

1878

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.3

70.2

551

2437

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.2

70.1

279

875

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

69.9

5676

45000

R40.2

ICD-10 Finland

Coma, unspecified

3.3

69.8

270

832

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.8

69.8

354

1273

P15

ICPC

Chronic alcohol abuse

2.0

69.7

781

3963

R49.01

ICD-10 Finland

Functional dysphonia

2.0

69.6

788

4012

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.2

69.4

631

2962

L04AX07

ATC

dimethyl fumarate; oral

5.0

69.4

147

292

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

69.4

1068

6008

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.7

69.4

382

1434

AA400

NOMESCO Finland

Electroconvulsive therapy

3.4

69.3

256

767

SPAT1043

SPAT

Audiometry

1.5

69.2

2604

18198

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

69.1

3009

21610

R20.0

ICD-10 Finland

Anaesthesia of skin

3.2

68.9

273

854

L18

ICPC

Muscle pain

1.7

68.8

1185

6889

XP60W, ,

NOMESCO Finland

7.4

68.8

134

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.3

68.7

527

2308

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

68.3

1401

8538

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

68.3

4892

38086

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

68.3

7067

57821

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

68.2

765

3883

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

68.2

1051

5915

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

68.1

1648

10467

P25

ICPC

Phase of life problem adult

1.8

68.1

1162

6736

TKC22

NOMESCO Finland

Catheterisation instruction

2.1

68.1

639

3038

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

67.8

2458

17047

C08CA05

ATC

nifedipine; systemic

1.6

67.8

1556

9756

D07AA02

ATC

hydrocortisone; topical

1.4

67.6

3676

27423

L05

ICPC

Flank/axilla symptom/complaint

1.6

67.4

1726

11109

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

67.3

1416

8685

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.7

67.3

362

1343

N06AA04

ATC

clomipramine; systemic

2.4

67.2

456

1893

R31

ICD-10 Finland

Unspecified haematuria

1.5

67.2

2676

18900

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

67.0

6367

51507

G70.0

ICD-10 Finland

Myasthenia gravis

4.7

66.9

155

332

G83.4

ICD-10 Finland

Cauda equina syndrome

4.4

66.9

168

384

H29

ICPC

Ear symptom/complaint other

1.4

66.9

3355

24692

F01

ICPC

Eye pain

1.9

66.9

843

4453

Z50.1

ICD-10 Finland

Other physical therapy

1.7

66.5

1371

8365

C09CA01

ATC

losartan; oral

1.3

66.5

6810

55609

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

66.4

2487

17356

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

66.4

8847

74555

N04BB01

ATC

amantadine; oral

2.5

66.2

431

1755

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

66.1

2870

20592

S06

ICPC

Rash localized

1.6

66.0

1531

9622

R07.2

ICD-10 Finland

Precordial pain

2.2

66.0

586

2726

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

65.9

588

2740

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.9

65.9

892

4822

PEN25

NOMESCO Finland

Plastic repair of superficial femoral artery

5.0

65.8

140

279

R30.0

ICD-10 Finland

Dysuria

1.7

65.7

1184

6969

J01MA12

ATC

levofloxacin; systemic

1.3

65.7

4821

37643

R03BA02

ATC

budesonide; inhalant

1.3

65.7

4756

37064

N07XX02

ATC

riluzole; oral

8.1

65.6

107

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

65.4

2574

18131

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.0

65.4

183

454

OAB50, ,

SPAT

1.5

65.4

2169

14774

L09

ICPC

Arm symptom/complaint

1.7

65.3

1337

8143

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

65.3

2636

18661

A08

ICPC

Swelling

1.6

65.2

1539

9715

RS222, ,

NOMESCO Finland

2.7

65.0

348

1288

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

6.1

65.0

113

187

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

2.5

64.8

423

1725

SPAT1251

SPAT

Organisation of medication

1.9

64.8

884

4791

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

64.7

1262

7589

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

64.3

1058

6069

164

Kela drug reimbursment

Fingolimod

5.4

64.2

126

234

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.4

64.0

446

1874

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.0

63.8

659

3248

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

63.7

3446

25667

R41.3

ICD-10 Finland

Other amnesia

1.9

63.7

794

4178

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

63.7

3369

25005

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

63.6

1912

12754

XF402

NOMESCO Finland

ECG with work load test

1.4

63.5

2620

18618

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

63.4

2003

13500

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

4.4

63.2

160

368

K04.0

ICD-10 Finland

Pulpitis

1.5

63.2

2293

15898

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.9

63.1

849

4581

P27

ICPC

Fear of mental disorder

2.6

62.8

374

1460

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

5.4

62.6

124

232

A07AA02

ATC

nystatin; oral

1.6

62.6

1491

9430

U29

ICPC

Urinary symptom/complaint other

1.9

62.4

855

4639

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.7

62.3

342

1282

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.7

62.3

1115

6549

F80.1

ICD-10 Finland

Expressive language disorder

3.0

62.2

277

928

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

62.1

7883

65964

E86

ICD-10 Finland

Volume depletion

2.0

62.1

657

3267

XA400

NOMESCO Finland

EEG

3.6

61.9

203

563

A06AC51

ATC

ispaghula, combinations; oral

1.7

61.9

1245

7548

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.0

61.8

716

3676

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

61.7

1659

10793

N06AX17

ATC

milnacipran; oral

2.8

61.7

303

1072

A46

ICD-10 Finland

Erysipelas

1.4

61.5

3858

29408

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

61.3

3539

26628

PE1AT

NOMESCO Finland

Femoral artery PTA

2.6

61.3

345

1310

H02

ICPC

Hearing complaint

1.3

61.3

3929

30046

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

61.2

1366

8502

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

61.2

6207

50551

S04

ICPC

Lump/swelling localized

1.4

61.1

2992

21909

L99

ICPC

Musculoskeletal disease other

2.0

61.1

629

3097

S22

ICPC

Nail symptom/complaint

1.5

61.0

1818

12102

E87.6

ICD-10 Finland

Hypokalaemia

1.8

60.9

916

5116

D07AC13

ATC

mometasone; topical

1.3

60.8

7678

64174

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.8

60.8

990

5661

G91.1

ICD-10 Finland

Obstructive hydrocephalus

4.7

60.7

140

299

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.2

60.7

536

2489

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.3

60.6

453

1963

EC1VA, ,

NOMESCO Finland

1.7

60.6

1274

7812

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

60.6

2695

19407

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

60.4

1862

12485

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

60.2

1397

8778

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

60.2

1395

8763

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.2

60.1

542

2537

L29.9

ICD-10 Finland

Pruritus, unspecified

1.9

60.1

771

4096

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

60.1

2226

15492

B01AC07

ATC

dipyridamole; systemic

1.8

60.0

972

5549

J01FA09

ATC

clarithromycin; systemic

1.2

60.0

8266

69751

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

59.8

2299

16113

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

5.3

59.8

121

231

C09AA05

ATC

ramipril; oral

1.3

59.8

6370

52170

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.7

59.7

1266

7778

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

59.6

721

3756

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.5

59.6

390

1593

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

59.4

1277

7874

R06.2

ICD-10 Finland

Wheezing

1.7

59.4

1186

7175

XQ800

NOMESCO Finland

Prick test

1.5

59.4

1850

12429

F43.00

ICD-10 Finland

Acute stress reaction mild

2.0

59.3

658

3327

P72

ICPC

Schizophrenia

2.3

59.0

460

2029

G25.1

ICD-10 Finland

Drug-induced tremor

5.9

59.0

106

181

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

59.0

908

5106

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

58.9

1400

8848

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

5.7

58.9

110

195

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

3.4

58.9

208

606

L84

ICPC

Back syndrome without radiat pain

1.7

58.8

1250

7684

N03AB02

ATC

phenytoin; systemic

2.8

58.8

298

1072

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

58.8

1464

9356

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

3.0

58.8

263

884

D19

ICPC

Teeth/gum symptom/complaint

1.2

58.8

8484

71931

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

58.7

5620

45403

I20.09

ICD-10 Finland

Unstable angina

1.6

58.5

1393

8808

F31

ICD-10 Finland

Bipolar affective disorder

2.6

58.5

349

1364

IGV01

NOMESCO Finland

Psychiatric network contact

2.7

58.5

312

1153

R83

ICPC

Respiratory infection other

1.3

58.4

6826

56503

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

3.4

58.3

207

605

R30.1

ICD-10 Finland

Vesical tenesmus

2.0

58.3

610

3020

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

58.3

1489

9572

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

58.1

1357

8541

A98

ICPC

Health maint/preventive medicine

1.5

58.0

30822

299448

H50.52

ICD-10 Finland

Exophoria

2.6

57.9

334

1284

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.3

57.9

423

1815

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

57.8

522

2446

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

57.8

1147

6929

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.2

57.7

473

2131

G11.8

ICD-10 Finland

Other hereditary ataxias

18.4

57.7

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

57.7

1769

11845

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

57.6

641

3244

OAB93, ,

SPAT

1.5

57.6

1670

11046

SPAT1281

SPAT

Other administrative function

1.5

57.5

1995

13702

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.0

57.4

656

3351

PLAK0, ,

NOMESCO Finland

3.1

57.4

238

766

SBB10

NOMESCO Finland

Dental impressions

1.5

57.4

1749

11696

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

5.9

57.2

102

173

E000001, ,

ATC

1.3

57.2

5143

41200

N06

ICPC

Sensation disturbance other

2.6

57.1

326

1247

UJF92

NOMESCO Finland

Capsular endoscopy

2.1

57.1

581

2848

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

57.0

2151

15016

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

57.0

831

4598

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.4

57.0

410

1748

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.3

56.8

455

2031

N02CC04

ATC

rizatriptan; oral

1.6

56.7

1372

8709

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

3.3

56.6

218

671

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.4

56.6

401

1698

T74.1

ICD-10 Finland

Physical abuse

2.2

56.6

481

2200

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

56.6

912

5200

N76.0

ICD-10 Finland

Acute vaginitis

1.5

56.6

1621

10695

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

56.5

411

1760

OAB71, ,

SPAT

2.8

56.5

278

985

F10.24

ICD-10 Finland

Alcohol depence active use

2.4

56.4

392

1646

SPAT1167

SPAT

Insertion of urinary catheter

1.9

56.4

784

4275

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

5.6

56.3

107

193

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

56.2

1413

9050

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

56.2

7855

66303

AAF00

NOMESCO Finland

Ventriculostomy

3.5

56.0

192

549

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.0

55.9

649

3334

R01AD11

ATC

triamcinolone; nasal

1.5

55.8

2122

14835

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3025159) Blasts/Leukocytes in Blood

4504

25013

1.93

322.19

5.3

4.6

0.10

0.33

5.26

989

6598

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

9848

68625

1.62

315.67

1.4

1.3

1.36

1.67

u/ml

2.14

3104

18234

(3002179) Metamyelocytes/Leukocytes in Blood

4431

24706

1.92

312.43

4.6

4.2

0.62

0.72

1.39

1139

7653

(3018418) pH of Serum or Plasma

12907

87751

1.77

307.65

4.5

4.3

7.40

0.02

10085

62033

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2883

6368

4.86

307.65

1.4

498.21

554.12

mg/l

2.27

2758

6115

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

15211

116524

1.57

307.65

4.9

3.9

0.15

0.52

estimate

2.01

4645

25626

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8470

55636

1.70

307.65

5.0

3.9

290.41

468.10

ng/l

4.42

6030

43236

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2605

5632

4.93

307.65

1.5

1568.22

2343.07

e6/l

0.32

2202

4348

(3031040) Bacteria [#/volume] in Urine by Automated count

23455

191200

1.79

307.65

6.4

4.7

1741.51

1708.49

e6/l

0.03

643

2486

(3021601) Nitrite [Presence] in Urine by Test strip

19385

154942

1.61

307.65

4.9

3.9

0.00

estimate

1.95

5489

31249

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

16857

129218

1.62

307.65

2.4

2.1

95.80

96.23

pmol/l

0.57

9504

68947

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8038

48941

1.85

307.65

3.3

3.6

0.82

mmol/l

0.70

7578

45974

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

908

1184

7.85

307.65

1.1

1.08

1.15

u/l

0.75

397

458

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7645

49200

1.72

307.65

2.2

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

26084

222216

1.84

307.65

5.4

4.4

14.77

14.75

pmol/l

0.48

24595

204342

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19956

152979

1.77

307.65

6.3

6.6

10.79

11.63

umol/l

17.81

19135

145556

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

17251

132895

1.63

307.65

2.8

2.5

77.09

757.37

nmol/l

0.50

16003

120566

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

785

1369

5.85

307.65

1.4

1.5

5.39

6.00

u/l

1.02

660

1191

(3041096) Erythrocytes [Presence] in Urine by Automated

11575

82966

1.61

307.65

4.2

3.3

0.16

0.25

estimate

0.53

4655

24807

(3019069) Monocytes/Leukocytes in Blood

18048

138352

1.67

307.65

7.4

6.7

8.73

8.82

4.62

17221

129812

(3019309) Folate [Moles/volume] in Red Blood Cells

7910

48428

1.83

307.65

1.9

1.8

1213.46

1153.38

nmol/l

7.25

6346

36573

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

14075

106027

1.57

307.65

4.2

3.5

3.29

1.66

e6/l

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1330

2550

5.39

307.65

1.1

44.08

24.38

au/ml

—

(3037522) Nuclear Ab [Titer] in Serum

6805

41154

1.82

307.65

1.5

1.4

461.23

527.40

titre

2.44

1461

8716

(3024561) Albumin [Mass/volume] in Serum or Plasma

18087

131369

1.84

307.65

5.3

5.1

35.87

35.63

g/l

6.94

17107

122988

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4044

17911

2.43

307.65

1.4

1.3

41.86

52.23

au/ml

2.19

190

1133

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2545

5698

4.75

307.65

1.4

1.3

3.69

3.74

mmol/l

1.42

2418

5401

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1183

1589

7.68

307.65

1.1

—

(3006504) Eosinophils/Leukocytes in Blood

18003

137989

1.67

307.65

7.3

6.6

2.78

2.84

3.84

17197

129383

(3021960) Folate [Moles/volume] in Serum or Plasma

12422

83208

1.79

307.65

1.9

1.7

19.73

20.20

nmol/l

2.82

11058

70744

(3022096) Basophils/Leukocytes in Blood

17984

138006

1.67

307.65

7.4

6.7

0.67

0.68

0.87

17167

129315

(4027681) Cerebrospinal fluid IgG ratio and IgG index

1018

1278

8.18

307.65

1.2

0.60

0.69

ratio

0.89

639

709

(3015377) Calcium [Moles/volume] in Serum or Plasma

14142

100474

1.71

307.65

3.0

3.6

2.35

mmol/l

10.36

13147

91198

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7323

44346

1.84

307.65

2.3

2.2

29.53

29.67

0.98

7117

43143

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2556

5575

4.88

307.65

1.5

20.07

35.11

e6/l

1.24

2037

4038

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9453

64170

1.66

307.65

2.0

1.8

1.09

1.27

mg/l

5.79

7255

49959

(3000850) Epithelial cells [#/volume] in Urine

10257

65851

1.81

307.65

3.3

2.7

5.67

5.65

e6/l

0.04

9570

59751

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4323

19472

2.40

307.65

2.6

2.4

20.10

21.84

au/ml

0.67

374

2177

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

1309

1739

7.79

307.65

1.2

1.1

38.70

45.65

mg/l

2.89

1104

1486

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

15083

108287

1.72

307.65

4.8

3.7

87.47

63.38

ng/l

0.34

10581

74503

(3013650) Neutrophils [#/volume] in Blood by Automated count

20938

167599

1.69

307.65

10.1

9.7

4.15

e9/l

0.01

18878

144774

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1316

2456

5.54

307.65

1.1

59.65

66.51

au/ml

0.11

(3013115) Eosinophils [#/volume] in Blood

20051

154772

1.76

307.65

7.5

6.6

0.19

e9/l

4.81

18162

134700

(3032080) INR in Blood by Coagulation assay

18745

132760

1.96

307.65

15.4

15.0

1.23

1.26

inr

16.02

16609

110381

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2356

10146

2.42

307.65

2.2

2.3

310.32

591.54

ug/l

7.07

2170

9629

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

662

1095

6.15

307.65

1.3

1.2

64.85

63.41

0.09

133

(3019198) Lymphocytes [#/volume] in Blood

19799

153338

1.73

307.65

7.3

6.4

1.90

1.92

e9/l

1.00

18029

134542

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

959

1935

5.07

307.65

1.3

1.95

2.18

mmol/l

5.19

898

1793

(3035350) Ketones [Presence] in Urine by Test strip

19699

156681

1.64

307.65

5.0

3.9

4.12

3.82

estimate

0.10

5624

31940

(3037467) Urinalysis macro (dipstick) panel - Urine

23840

198808

1.72

307.65

5.9

4.6

2.37

48.17

0.52

301

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

938

1279

7.52

307.65

1.1

3.10

7.94

nmol/l

1.96

162

241

(3006315) Basophils [#/volume] in Blood

19634

150316

1.76

307.65

7.2

6.4

0.04

e9/l

1.97

17561

128743

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20413

146754

2.03

307.65

8.1

7.3

1.21

mmol/l

0.24

17906

126768

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1272

1667

7.89

307.65

1.1

260.02

270.50

mg/l

0.53

1113

1503

(3013826) Glucose [Moles/volume] in Serum or Plasma

22429

170248

2.00

307.65

6.4

5.1

6.55

6.70

mmol/l

23.82

21739

160862

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17409

132067

1.68

307.65

7.4

6.7

1.21

mmol/l

1.14

16392

122242

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

26043

212275

2.09

307.65

5.5

4.4

11.63

12.15

mm/h

7.49

24895

198586

(3029937) Albumin [Presence] in Urine by Test strip

12025

85238

1.65

307.65

5.2

4.1

0.00

estimate

0.11

5283

28671

(3009261) Glucose [Presence] in Urine by Test strip

19770

157815

1.63

307.65

5.0

3.9

0.01

0.27

estimate

2.56

5312

30286

(3018010) Neutrophils/Leukocytes in Blood

17929

139066

1.64

307.65

7.2

6.5

57.32

57.34

0.11

17407

132807

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13795

93090

1.83

307.65

3.1

2.7

57.31

70.16

u/l

1.24

13009

86160

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11959

85781

1.62

307.65

3.3

3.2

1252.41

1426.60

ng/l

3.63

10340

73847

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11249

78855

1.65

307.65

2.6

2.4

2.71

2.82

mg/l

5.58

10005

68018

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

16466

86937

2.79

307.65

2.8

2.1

185.67

209.67

u/l

3.23

15824

82011

(3002582) Erythrocytes [#/volume] in Urine

13214

96434

1.62

307.65

4.2

3.4

73.99

84.79

e6/l

0.38

10831

73066

(3005719) IgG [Mass/volume] in Serum or Plasma

4285

22372

2.05

307.65

2.9

10.31

10.59

g/l

4.25

3930

20726

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

9790

59121

1.93

307.65

1.8

1.7

37801287.96

30494643.41

pmol/l

0.58

8476

48947

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

26440

219905

2.03

307.65

9.0

8.3

78.03

79.60

u/l

5.57

25516

208753

(3002030) Lymphocytes/Leukocytes in Blood

18285

141684

1.65

307.65

7.4

6.6

27.75

27.77

0.06

17557

134398

(3001604) Monocytes [#/volume] in Blood

19577

149894

1.76

307.65

7.2

6.4

0.58

0.59

e9/l

3.38

17511

128416

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5335

27410

2.13

307.65

2.2

2.4

365.82

381.00

nmol/l

6.40

5013

25460

(3019550) Sodium [Moles/volume] in Serum or Plasma

30696

282835

2.29

302.56

26.1

18.8

139.52

139.65

mmol/l

16.76

30410

277274

(3020630) Protein [Mass/volume] in Serum or Plasma

4345

24342

1.90

301.12

2.4

2.7

66.82

66.23

g/l

6.06

4029

22269

(3001122) Ferritin [Mass/volume] in Serum or Plasma

17729

142245

1.53

299.26

3.6

3.2

119.23

122.46

ug/l

0.81

16721

132915

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

28944

261365

1.90

298.51

6.7

5.4

1.82

1.91

mu/l

34.06

27631

242617

(3009466) Valproate [Moles/volume] in Serum or Plasma

1183

3704

3.27

298.37

5.6

5.2

371.49

358.43

umol/l

2.09

1071

3203

(3017181) Myelocytes/Leukocytes in Blood

4557

26019

1.87

297.46

4.8

4.4

0.90

0.95

0.51

1188

8013

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

955

2612

3.73

296.86

1.5

—

(3021440) Promyelocytes/Leukocytes in Blood

4394

24854

1.89

295.18

4.8

4.4

0.11

0.12

0.44

1025

6890

(3023103) Potassium [Moles/volume] in Serum or Plasma

30704

283331

2.27

294.82

26.3

18.9

3.97

mmol/l

0.03

30389

277309

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4042

22340

1.92

291.17

4.2

4.0

1.23

mmol/l

1.22

3609

19161

(3021589) Normoblasts [#/volume] in Blood

16411

129969

1.52

290.88

14.6

11.4

0.00

e9/l

0.71

14112

105270

(3023368) Bacteria identified in Blood by Culture

11092

81289

1.55

277.83

4.9

4.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

30336

279637

2.10

275.49

23.0

16.0

21.30

24.66

mg/l

70.48

26626

230494

(3018095) Leukocytes [#/volume] in Urine

14271

110673

1.51

273.04

4.9

4.0

107.64

99.33

e6/l

0.39

11140

76987

(3044889) 12 lead EKG panel

22840

195712

1.55

268.37

4.7

4.0

0.35

2992.56

1.34

398

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2387

11213

2.22

266.79

1.3

1.2

0.97

0.82

u/ml

0.18

156

922

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7927

54298

1.61

263.64

1.4

1.3

33.79

35.12

iu/ml

0.21

2237

16428

(3026782) Osmolality of Urine

8137

56426

1.59

255.54

3.3

3.0

508.70

534.46

mosm/kgh2o

23.35

7341

49401

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8268

57621

1.58

253.85

2.7

3.0

2.44

2.45

mmol/l

6.32

7479

51499

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2450

11998

2.12

245.71

1.8

2.0

39.51

39.57

u/l

0.05

2223

10641

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12681

97605

1.49

242.23

3.6

3.3

33.51

33.62

u/l

0.04

12035

92119

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3976

23116

1.82

240.99

2.8

2.3

5.70

7.47

ug/l

6.74

3555

20118

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7334

50240

1.59

240.20

1.4

1.3

7.14

11.75

u/ml

5.72

3230

19247

(3024869) Neuronal Ab [Presence] in Serum

300

347

8.71

237.12

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

8419

59787

1.55

234.46

1.6

1.5

2.29

2.40

g/l

5.82

5537

36694

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

509

1030

5.00

234.36

1.1

116.19

555.33

ng/l

1.94

133

290

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6011

39463

1.64

233.74

6.2

1.04

1.05

mmol/l

0.51

5674

36690

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

413

723

5.77

223.29

1.3

1.2

22.11

20.98

0.08

122

(3045716) Anion gap in Serum or Plasma by calculation

888

2825

3.20

217.61

3.1

3.0

10.09

10.89

mmol/l

7.44

873

2788

(3023410) Appearance of Cerebral spinal fluid

876

2782

3.21

215.28

1.6

1.7

—

(40768797) Stomach Pathology biopsy report

5987

40082

1.60

212.42

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

10995

83887

1.47

211.46

4.1

3.3

0.38

0.41

e6/l

0.96

8809

61001

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3937

23889

1.74

203.61

2.8

2.5

0.44

0.40

e6/l

0.31

3830

22809

(3022948) Iron [Moles/volume] in Serum or Plasma

7409

52508

1.53

203.19

2.8

2.6

13.01

13.02

umol/l

0.05

6892

48915

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

384

691

5.61

201.62

1.4

1.2

135.20

123.42

nmol/l

0.57

281

491

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5515

36675

1.60

199.81

2.1

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

22054

192390

1.44

197.34

4.2

3.3

49.50

47.28

u/l

2.67

21014

180903

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3689

22237

1.74

194.73

3.3

3.0

181.83

208.15

ng/l

2.15

3351

20410

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5212

34396

1.61

194.36

2.1

1.8

—

(3011048) Pyruvate [Moles/volume] in Blood

164

105

15.68

190.43

1.3

1.4

76.72

88.82

umol/l

2.10

150

(3016502) Oxygen saturation in Arterial blood

4711

30466

1.64

190.40

7.9

8.0

95.57

95.59

0.07

4555

29417

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

606

1653

3.71

188.78

1.0

37.80

42.34

ng/l

0.63

404

1201

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

603

1645

3.71

187.81

1.0

277.83

353.50

ng/l

2.29

416

1212

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

604

1650

3.71

187.74

1.0

760.53

738.42

ng/l

0.49

396

1175

(36304419) Bacteria [Presence] in Urine

10366

79737

1.44

184.45

4.0

3.3

1.81

253.51

estimate

1.04

360

(3028626) Oxygen [Partial pressure] in Capillary blood

1685

7959

2.18

183.92

3.7

4.1

8.45

8.36

kpa

1.32

1644

7754

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6891

48982

1.51

183.43

2.8

2.6

2.35

2.33

g/l

2.84

6384

45216

(3019977) pH of Arterial blood

5132

34344

1.58

178.91

7.8

7.7

7.42

1.90

3135

18374

(3027801) Oxygen [Partial pressure] in Arterial blood

5118

34270

1.58

177.87

7.8

7.7

12.09

12.51

kpa

7.69

4938

32951

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5120

34289

1.58

177.81

7.8

7.7

5.10

5.08

kpa

0.95

4945

32974

(3015736) pH of Urine

15233

125902

1.39

176.81

4.2

3.5

6.28

6.23

7.43

9132

69162

(3003396) Base excess in Arterial blood by calculation

5085

34070

1.58

176.08

7.7

7.6

1.20

0.87

mmol/l

7.44

4259

28103

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5000

33524

1.58

172.22

2.0

1.7

1.57

1.45

24.16

4431

29471

(3048689) Calprotectin [Mass/mass] in Stool

5622

38825

1.54

169.49

2.4

125.51

132.83

ug/g

0.87

4489

30731

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

28186

260623

1.57

168.16

7.1

6.3

39.42

39.14

mmol/mol

5.86

26816

244063

(3021901) Oxygen saturation in Capillary blood

1344

6026

2.28

166.38

3.0

3.1

90.73

90.01

3.67

1305

5862

(42870588) Differential panel, method unspecified - Blood

12576

101390

1.39

165.91

6.8

6.5

7.66

4.94

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2998

17811

1.75

165.00

7.4

6.8

24.86

24.46

mmol/l

7.28

2893

17049

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

370

777

4.80

163.05

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4570

30400

1.58

161.91

4.6

4.1

5.89

5.81

kpa

7.31

4463

29700

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4321

28429

1.60

160.28

8.6

8.5

122.69

120.76

g/l

8.17

4234

27786

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6308

45170

1.49

158.69

2.8

2.7

22.44

22.43

0.03

5853

41924

(3023183) Ammonium ion [Moles/volume] in Plasma

1355

6215

2.23

158.69

2.9

2.6

30.82

33.74

umol/l

5.04

1256

5571

(3013512) EKG study

12071

97287

1.38

156.88

3.9

3.7

0.74

0.00

236

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2074

11179

1.91

156.54

2.1

2.4

2.72

2.92

g/l

17.99

1911

10091

(3020564) Creatinine [Moles/volume] in Serum or Plasma

31053

295434

1.92

155.42

28.3

20.7

77.78

77.15

umol/l

2.18

30871

291987

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

28593

266164

1.57

155.39

21.4

15.6

82.13

81.34

ml/min/173m2

8.22

27232

245004

(3019150) Specific gravity of Urine by Refractometry

8957

68841

1.41

153.64

5.1

4.0

1.02

1.13

kg/l

1.61

6551

45238

(3047181) Lactate [Moles/volume] in Blood

1679

8468

2.03

153.55

5.3

5.7

1.30

1.31

mmol/l

0.07

1515

7508

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1755

9003

2.00

153.04

1.9

1.7

0.23

g/l

1.12

1682

8585

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3449

21711

1.66

152.51

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2157

11878

1.87

152.27

2.2

2.4

7.22

7.40

g/l

6.05

1990

10791

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2154

11863

1.87

151.98

2.2

2.4

4.22

4.21

g/l

0.16

1989

10789

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2150

11841

1.87

151.69

2.2

2.4

3.53

3.75

g/l

11.37

1986

10765

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

28572

266214

1.56

151.38

5.7

5.1

5.95

5.92

mmol/l

5.19

26871

245480

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1786

9259

1.98

151.09

1.9

1.7

1.18

1.19

g/l

0.66

1720

8859

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1920

10212

1.93

150.68

3.1

24.92

24.65

mmol/l

2.37

1879

10031

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

16226

137716

1.35

148.51

3.0

2.8

—

estimate

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1902

10265

1.90

142.63

2.2

1.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

448

1207

3.75

142.10

1.4

2.1

29.64

28.27

umol/l

2.06

431

1131

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1881

10205

1.89

138.71

2.2

2.3

9.61

10.21

g/l

9.12

1703

9018

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2015

11191

1.85

138.05

2.3

2.0

—

(3012544) pH of Venous blood

4505

30870

1.53

137.81

4.7

4.2

7.38

1.56

2781

17798

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

467

1328

3.55

136.70

1.1

—

(3017732) Neutrophils [#/volume] in Blood

5210

36898

1.49

135.86

3.3

3.1

4.65

4.57

e9/l

0.22

4690

31702

(3045414) Leukocytes [Presence] in Urine

4173

28289

1.54

133.78

2.2

2.1

0.02

estimate

0.85

1131

5480

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1912

10578

1.86

132.46

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2854

17805

1.66

129.52

2.1

1.9

1.28

1.32

g/l

0.49

2655

16373

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2224

12986

1.76

128.69

5.1

4.9

1.65

1.62

0.53

2121

12332

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2039

11687

1.79

125.62

1.8

1.7

0.32

0.30

mg/l

0.68

941

5475

(3027945) Reticulocytes/Erythrocytes in Blood

4902

34875

1.48

123.71

2.7

2.6

1.77

0.04

4423

31046

(3013247) Albumin in CSF/Albumin in Serum or Plasma

266

536

4.99

123.16

1.1

6.84

7.06

mg/g

0.17

250

516

(3002032) Base excess in Venous blood by calculation

4290

29740

1.51

123.00

4.8

4.2

1.85

1.74

mmol/l

1.36

3779

26110

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

250

487

5.16

120.35

1.3

1.18

mmol/l

0.51

250

487

(3023420) DNA double strand Ab [Units/volume] in Serum

2111

12372

1.75

120.32

2.1

1.8

7.07

7.49

iu/ml

0.25

591

2817

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

30700

293391

1.70

119.06

14.9

12.1

25.79

25.98

u/l

0.99

30136

285089

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

20.51

116.04

1.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3083

20117

1.59

115.83

3.9

4.1

5.18

5.13

kpa

2.71

2960

19155

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

475

1518

3.16

115.39

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

2999

19467

1.59

115.17

1.4

1.3

207.02

241.15

u/ml

1.00

2803

18132

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2099

12466

1.73

113.94

1.5

1.6

9.98

14.98

iu/ml

1.02

305

(3024666) Lithium [Moles/volume] in Serum or Plasma

461

1467

3.17

112.80

13.2

13.5

0.62

mmol/l

0.32

426

1351

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4843

34989

1.45

111.67

3.7

4.5

236.76

244.29

u/l

2.57

4595

33245

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2923

19015

1.59

111.00

3.2

3.5

4.44

4.49

pmol/l

1.67

2630

17136

(3045424) Erythrocytes [Presence] in Urine

2321

14317

1.67

109.26

2.1

0.00

0.16

estimate

1.22

1021

4192

(3020891) Body temperature

2205

13444

1.69

108.48

4.9

4.6

36.93

36.90

°c

2.04

2182

13314

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1779

10283

1.77

106.03

2.3

2.5

0.57

0.86

g/l

4.12

1560

8789

(3028707) Methadone [Presence] in Urine by Screen method

1005

4820

2.12

104.69

3.2

2.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

889

4070

2.22

104.19

1.3

0.22

0.24

nmol/l

0.12

263

(3009508) Creatinine [Moles/volume] in Urine

12045

101251

1.30

103.64

3.7

3.5

7.51

mmol/l

0.04

10396

85740

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

874

3993

2.22

102.96

1.3

0.59

1.81

nmol/l

1.37

843

3848

(3014111) Lactate [Moles/volume] in Serum or Plasma

3869

27189

1.48

102.19

7.9

7.7

1.34

mmol/l

0.11

3793

26653

(3009343) pH of Capillary blood

2950

19601

1.55

101.68

3.9

4.1

7.41

7.42

0.89

2523

16282

(1616796) Gas panel - Central venous blood

1250

6560

1.94

101.33

4.0

3.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1587

8989

1.80

101.22

1.3

31.61

41.31

u/ml

0.81

456

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1909

11412

1.71

100.84

2.8

2.3

4550.18

5912.02

u/l

1.26

661

4511

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1494

8318

1.83

100.82

2.2

2.4

0.00

g/l

0.30

1290

7286

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

203

387

5.27

100.20

1.1

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4024

28608

1.46

99.98

4.2

3.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

3660

25561

1.49

99.54

4.1

3.6

4.56

kpa

0.05

3567

24896

(3020779) Urea [Moles/volume] in Serum or Plasma

3829

27004

1.47

99.09

7.9

7.6

9.30

10.00

mmol/l

7.86

3677

25779

(3010421) pH of Blood

1585

9041

1.79

98.68

4.1

3.6

7.41

0.27

1570

8900

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1536

8696

1.80

98.06

2.2

2.4

0.02

0.03

g/l

0.51

1407

7784

(3018405) Lactate [Moles/volume] in Arterial blood

1593

9158

1.78

96.54

4.4

4.1

1.36

1.39

mmol/l

0.55

1560

8975

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

422

1398

3.04

96.44

1.5

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1349

7399

1.86

95.44

1.3

31.25

13.93

u/ml

0.71

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

13.78

95.24

1.1

0.54

0.07

mg/l

0.45

(3003181) Sodium [Moles/volume] in Urine

1044

5270

2.01

94.62

1.5

1.4

62.66

61.85

mmol/l

0.26

862

4177

(3020961) Endomysium IgA Ab [Titer] in Serum

2238

14172

1.62

94.45

1.1

119.88

207.08

titre

1.84

385

(3027315) Oxygen [Partial pressure] in Blood

1145

5974

1.95

94.37

4.5

3.9

8.76

8.61

kpa

2.30

1130

5819

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

773

3481

2.25

94.29

1.3

0.18

0.21

nmol/l

2.09

620

2707

(3012501) Base excess in Blood by calculation

1139

5940

1.95

93.99

4.5

3.9

2.42

2.51

mmol/l

0.54

796

4001

(3013290) Carbon dioxide [Partial pressure] in Blood

1139

5942

1.95

93.90

4.5

3.9

5.05

4.99

kpa

2.47

1124

5788

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3005

20399

1.52

93.44

8.6

8.4

24.78

24.76

mmol/l

0.14

2988

20240

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1229

6591

1.90

93.25

1.3

1.2

36.16

45.82

u/ml

1.32

122

590

(3020191) Ethanol [Moles/volume] in Serum or Plasma

575

2287

2.54

92.72

1.9

1.4

1.21

1.25

promille

0.21

456

1788

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1040

5306

1.99

91.44

1.3

71.67

148.00

titre

1.24

105

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1031

5261

1.99

90.59

1.3

324.69

253.50

titre

0.44

399

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2601

17235

1.55

90.24

3.7

4.0

1.99

1.69

mmol/l

3.96

1889

12674

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

934

4612

2.05

89.94

1.6

1.5

13.35

14.29

u/ml

0.08

100

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

25216

234876

1.31

89.02

26.7

19.6

13.68

13.62

9.76

25014

231846

(3007930) Methemoglobin/Hemoglobin.total in Blood

1921

11898

1.65

88.42

5.6

5.1

0.85

0.88

1.85

1825

11269

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3958

28680

1.43

87.91

2.2

2.4

0.21

g/l

3.64

3684

26719

(40767503) Oxygen content in Capillary blood by calculation

1138

6077

1.90

87.42

2.9

2.6

16.83

16.39

4.97

1107

5944

(3021387) Prolactin [Units/volume] in Serum or Plasma

1716

10407

1.68

85.58

1.8

1.7

312.47

303.80

mu/l

0.40

1580

9419

(3011412) CD3 cells [#/volume] in Blood

629

2706

2.35

85.43

2.9

2.4

1348.94

1194.83

e6/l

2.25

565

2343

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1369

7801

1.79

85.33

2.2

2.4

0.00

g/l

-0.00

1288

7270

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

102

110

9.29

85.18

1.0

—

(3025941) Bacteria identified in Stool by Culture

2413

15927

1.55

84.98

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

722

3316

2.20

83.92

15.9

6.2

7.35

mmol/l

0.01

606

2730

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1520

8978

1.73

83.54

1.5

1.4

290.79

271.01

ug/g

3.03

930

5167

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

558

2303

2.45

83.16

2.2

2.6

19.38

19.14

nmol/l

0.23

534

2184

(3026493) Urate [Moles/volume] in Serum or Plasma

9287

77138

1.28

82.58

2.9

2.7

336.38

341.52

umol/l

5.00

8198

68049

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1441

8441

1.74

81.56

1.3

4.77

6.15

u/ml

0.45

128

791

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

216

518

4.19

80.70

1.1

1.2

—

(1175426) CD3 cells/Lymphocytes in Blood

532

2186

2.46

80.06

2.8

2.1

74.41

72.07

3.09

519

2099

(3000991) Gas panel - Venous blood

3671

26656

1.42

80.02

9.3

9.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2521

17019

1.52

79.87

10.1

9.8

16.30

15.99

5.31

2440

16442

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1432

8435

1.73

79.42

1.4

1.3

8.35

7.29

u/ml

0.21

191

1213

(3007461) Platelets [#/volume] in Blood

31299

303435

1.65

79.10

34.0

24.4

252.70

252.16

e9/l

0.77

30976

297097

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3205

22769

1.45

78.62

3.8

4.1

87.35

90.12

ng/l

0.89

2770

19757

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

375

1305

2.89

78.57

2.4

2.1

134.73

124.58

umol/l

0.25

182

674

(3028271) Lactate [Moles/volume] in Capillary blood

876

4440

2.00

78.42

2.2

1.8

1.68

1.73

mmol/l

0.79

855

4315

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

526

2172

2.44

78.32

1.1

281.43

292.34

mg/l

2.91

506

1963

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

250

682

3.68

78.04

1.1

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

31299

303527

1.65

77.83

33.9

24.3

91.26

91.00

19.48

31128

300397

(3033658) Prothrombin time (PT) actual/Normal

9045

75315

1.28

77.77

4.9

4.2

89.84

89.44

0.79

8809

73674

(3035941) MCH [Entitic mass]

31298

303523

1.64

77.71

33.9

24.3

30.34

30.28

7.81

31127

300388

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

31299

303543

1.64

77.60

34.7

24.9

40.19

40.58

6.10

31124

300292

(3044242) Glucose [Moles/volume] in Arterial blood

405

1480

2.76

77.44

2.1

1.9

7.80

8.21

mmol/l

1.31

405

1480

(3026361) Erythrocytes [#/volume] in Blood

31298

303553

1.64

77.30

34.0

24.4

4.45

4.48

e12/l

23.98

30917

296161

(3010813) Leukocytes [#/volume] in Blood

31300

303594

1.64

77.07

34.0

24.4

6.87

6.76

e9/l

12.71

30924

296214

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

246

671

3.68

76.81

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

31298

303610

1.64

76.51

34.3

24.6

133.91

134.67

g/l

17.48

31128

300538

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

166

339

4.91

75.82

2.3

2.5

—

(3012516) Albumin [Mass/volume] in Urine

10975

93795

1.25

75.10

3.7

3.5

51.58

49.48

mg/l

0.31

7367

59582

(40761536) Microorganisms panel - Urine sediment

3250

23338

1.43

75.03

5.3

3.9

—

(3019225) pH of Specimen

3715

27344

1.40

74.56

4.2

4.3

7.34

7.36

4.50

3007

19346

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4552

34671

1.36

74.08

2.7

2.8

7.38

8.71

umol/l

4.00

3865

30291

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

27323

258998

1.32

73.83

4.7

4.2

1.33

1.27

mmol/l

31.70

25638

239129

(3008295) Osmolality of Serum or Plasma

656

3053

2.17

73.77

1.5

1.4

279.50

278.41

mosm/kgh2o

0.55

512

2313

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

300

955

3.16

73.50

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

398

1488

2.69

72.83

1.1

—

(3042936) Bacteria identified in Isolate by Culture

5396

42268

1.33

72.71

2.2

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

501

2105

2.40

71.82

2.7

2.0

13.80

15.04

2.07

495

2048

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2773

19511

1.46

71.19

9.8

9.6

1.35

1.32

1.09

2756

19390

(3001186) Copper [Moles/volume] in Serum or Plasma

252

738

3.43

70.69

1.2

1.3

16.18

16.89

umol/l

1.47

229

637

(3023520) Reticulocytes [#/volume] in Blood

3651

27024

1.39

70.62

2.5

2.7

69.73

69.06

e9/l

0.52

2712

19794

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2235

15086

1.52

70.53

1.1

2.35

8.49

u/ml

1.15

162

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2601

18115

1.47

70.35

5.5

4.3

24.18

24.17

mmol/l

0.10

2573

17895

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2693

18910

1.46

69.80

10.0

9.9

0.65

0.64

1.09

2679

18803

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1375

8307

1.68

69.33

1.8

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1231

7261

1.72

67.81

2.3

2.2

130.97

129.28

g/l

1.70

1031

5544

(3020682) Albumin/Creatinine [Ratio] in Urine

11083

95607

1.24

67.72

4.3

4.2

9.50

8.88

mg/mmol

0.54

7157

59412

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1298

7794

1.69

66.94

1.9

2.1

10.02

11.79

mg/l

13.16

1220

7280

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

325

1152

2.84

65.90

2.7

2.4

57.16

51.23

umol/l

2.41

287

995

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1204

7149

1.71

64.71

1.3

1.2

6.32

5.29

u/ml

0.12

475

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

240

723

3.33

64.43

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

240

723

3.33

64.43

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

240

723

3.33

64.43

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

240

723

3.33

64.43

1.2

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

1275

7710

1.68

64.01

5.0

4.4

3.86

3.88

mmol/l

0.87

1267

7644

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

784

4115

1.93

63.38

1.1

17.14

3.27

—

(3023511) Choriogonadotropin [Units/volume] in Urine

975

5496

1.80

62.88

1.6

1.3

—

(3011985) Renin [Units/volume] in Plasma

788

4156

1.92

62.79

1.5

63.73

64.15

mu/l

0.02

722

3721

(3014007) Fractional oxyhemoglobin in Arterial blood

2728

19577

1.43

62.59

10.0

9.8

93.89

93.94

0.18

2715

19519

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

384

1539

2.51

61.06

18.2

20.2

1383.83

2504.91

nmol/l

0.82

371

1472

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1418

8922

1.61

60.82

1.3

—

(3039000) Anion gap in Blood by calculation

1013

5850

1.75

60.12

6.8

6.7

11.11

11.27

mmol/l

0.91

933

5283

(3018572) Chloride [Moles/volume] in Blood

1013

5851

1.75

60.09

6.8

6.7

104.70

105.09

mmol/l

1.62

933

5285

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

28526

273589

1.32

59.48

5.6

5.0

4.52

4.62

mmol/l

50.56

27051

256421

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

367

1459

2.53

59.38

1.1

1647.23

1512.46

miu/ml

1.39

367

1459

(3000494) Fungus identified in Specimen by Culture

4539

35632

1.32

58.89

1.6

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1554

10070

1.57

58.80

3.3

3.4

69.24

64.55

mg/l

0.09

1308

8568

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1552

10055

1.57

58.77

3.2

3.4

35.21

43.59

mg/l

2.47

1308

8553

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

28872

277471

1.33

58.62

6.3

5.7

2.62

2.70

mmol/l

39.57

27358

259063

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2837

20733

1.40

58.50

1.3

1.2

119.42

141.28

u/ml

2.29

1060

7751

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

127

258

4.93

58.46

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1469

9413

1.59

58.34

1.6

1.5

0.25

7.40

iu/ml

2.12

211

1841

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

124

252

4.93

57.06

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

724

3837

1.91

56.86

1.4

424.51

362.59

pmol/l

0.18

635

3262

(3028717) Thiamine [Mass/volume] in Blood

145

336

4.33

56.80

1.1

1.2

62.88

62.66

ug/l

0.04

145

336

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2107

14665

1.47

56.73

4.1

4.2

47.26

47.68

0.32

2073

14470

(3022806) Fractional oxyhemoglobin in Capillary blood

655

3368

1.96

56.28

2.1

1.8

90.25

89.68

1.88

646

3314

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

28336

271912

1.30

55.87

5.5

5.0

1.43

1.47

mmol/l

50.95

26808

253350

(3022145) Colonoscopy Study observation

4319

33915

1.31

55.62

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

1294

8180

1.60

54.37

3.8

2.7

—

(3010503) CD19 cells [#/volume] in Blood

383

1622

2.38

54.05

2.7

2.6

201.52

306.57

e6/l

0.59

376

1572

(3024139) IgG subclass 3 [Mass/volume] in Serum

605

3075

1.98

53.77

1.6

1.4

0.37

0.41

g/l

1.84

448

2230

(3028192) IgG subclass 2 [Mass/volume] in Serum

605

3076

1.98

53.72

1.6

1.4

2.81

2.93

g/l

0.93

446

2233

(3027135) IgG subclass 1 [Mass/volume] in Serum

605

3077

1.98

53.67

1.6

1.4

6.30

6.83

g/l

3.50

447

2233

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

105

196

5.37

53.23

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

3229

24474

1.35

52.87

1.2

—

(3037756) Immunofixation for Serum or Plasma

1011

6068

1.69

52.15

1.5

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2259

30966

0.71

51.90

1.8

1.9

3.46

3.45

ratio

0.22

1696

23616

(4062490) Immunoglobulin typing, IgG

591

3029

1.97

51.29

1.6

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1341

8676

1.57

51.00

1.6

1.4

11.24

10.36

u/l

1.36

1114

6930

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

350

1462

2.41

50.97

14.2

15.1

753.40

1710.45

nmol/l

0.56

333

1417

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1374

8940

1.56

50.97

3.1

3.3

12.16

4.70

ratio

0.44

823

5148

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

135

6.31

50.96

1.0

1.1

2.68

3.32

u/l

0.24

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2480

18140

1.40

50.56

1.9

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

425

1953

2.19

49.47

2.9

2.5

556.86

534.87

e6/l

0.30

346

1545

(3024980) IgG subclass 4 [Mass/volume] in Serum

858

4997

1.74

49.42

1.7

1.6

0.65

0.77

g/l

3.50

660

3914

(46235355) HIV 1 and 2 tests - Meaningful Use set

6576

55124

1.24

48.93

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1327

8647

1.56

48.88

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

680

3715

1.85

48.61

1.4

1.3

42.92

58.33

u/ml

0.87

227

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

580

3009

1.94

48.60

1.1

1.57

2.22

iu/ml

0.81

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1715

11811

1.48

48.57

2.1

1.9

2.49

2.08

ug/l

0.54

1497

10467

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

157

433

3.64

48.42

1.5

1.7

1.15

1.06

nmol/l

0.17

(3027273) Bicarbonate [Moles/volume] in Venous blood

1886

13238

1.45

48.39

3.7

3.6

25.50

25.19

mmol/l

3.69

1820

12832

(3017569) Oxygen content in Arterial blood

351

1510

2.34

47.86

2.2

16.36

15.80

2.50

351

1510

(3016879) Cocaine [Presence] in Urine

1596

10889

1.49

47.35

2.7

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

9691

84753

1.20

46.84

3.3

3.0

0.08

0.05

131

1975

(40760888) Immunoglobulin light chains.free panel - Serum

1060

6624

1.62

46.67

3.1

3.5

—

286.05

—

(4198724) Urine methamphetamine measurement

297

1199

2.49

46.63

3.3

2.2

—

(3008898) HLA-B27 [Presence]

1479

9968

1.51

46.58

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2129

15384

1.41

46.47

1.5

1.4

26.25

26.84

iu/l

0.35

1853

13138

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

426

2019

2.12

45.87

2.9

2.6

237.70

229.24

e6/l

0.35

365

1685

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2418

17960

1.37

44.70

9.6

24.32

24.26

mmol/l

0.45

2369

17530

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1195

7764

1.56

44.57

1.2

4.32

3.92

0.61

111

1060

(3051339) Copper [Moles/volume] in Blood

114

6.41

44.52

1.2

16.81

16.70

umol/l

0.07

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2955

22659

1.33

44.33

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

1677

11702

1.46

44.31

2.7

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

242

910

2.67

44.00

3.1

10.25

10.46

kpa

0.47

242

910

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

242

910

2.67

44.00

3.1

4.94

4.92

kpa

0.14

242

910

(3022621) pH of Urine by Test strip

3049

23512

1.33

43.96

3.0

2.6

6.14

6.07

3.93

2140

15620

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

292

1203

2.44

43.91

1.1

9.84

11.46

u/ml

0.10

142

(3007916) DNA double strand Ab [Titer] in Serum

121

299

4.06

43.65

1.3

56.67

153.27

titre

—

(3026389) Candida sp identified in Specimen by Organism specific culture

751

4369

1.73

43.45

1.5

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

225

822

2.75

43.28

1.1

2.71

5.10

u/ml

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

241

915

2.64

43.00

3.0

28.30

28.55

umol/l

0.12

177

698

(3036489) Thrombin time

1626

11364

1.45

42.58

2.2

20.91

21.18

0.73

1370

10123

(3028300) Cannabinoids [Presence] in Urine

1676

11795

1.44

42.29

2.7

1.9

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

609

3360

1.83

42.22

1.5

1.8

4160.00

2714.80

titre

—

123

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3814

30500

1.28

41.79

2.2

2.1

—

(3027008) Opiates [Presence] in Urine

1666

11766

1.44

41.23

2.6

1.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

356

1641

2.18

41.21

1.2

1.1

1.07

1.06

ratio

0.28

308

1348

(3017143) Hepatitis C virus Ab [Presence] in Serum

4244

34465

1.26

40.92

1.7

1.6

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1660

23027

0.71

40.29

1.6

1.7

3.41

3.46

mmol/l

0.92

1105

15644

(40758558) Short blood count panel - Blood

10054

89143

1.18

40.02

6.7

6.6

—

(3033942) Copper [Moles/time] in 24 hour Urine

6.64

39.75

1.0

1.5

0.24

1.08

umol/24h

1.58

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

712

4195

1.71

39.38

1.2

8.52

15.09

u/ml

0.88

174

(3010838) Calcium [Moles/time] in 24 hour Urine

836

5173

1.63

38.32

1.9

4.79

5.07

mmol/24h

1.09

761

4612

(3014148) Varicella zoster virus Ab [Titer] in Serum

673

3939

1.72

38.14

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

379

1845

2.07

38.11

1.1

0.96

2.36

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

491

2620

1.89

37.89

1.3

8.40

8.61

mmol/l

0.57

479

2474

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

120

328

3.67

37.61

1.4

1.3

42.57

52.82

1.35

157

(3027944) Amphetamines [Presence] in Urine

1627

11631

1.42

37.59

2.7

1.9

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

235

942

2.50

37.57

2.1

2.6

138.17

147.58

nmol/l

0.63

214

831

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

164

4.95

37.57

1.5

37.02

39.42

0.17

115

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

294

1304

2.26

37.45

4.1

4.0

—

(21494755) Public health laboratory ask at order entry panel

1948

26019

0.73

37.28

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1241

8445

1.49

37.22

1.5

15.51

13.62

iu/ml

0.15

197

(3049717) Cytology report of Urine Cyto stain

1532

10870

1.43

36.91

2.4

2.7

—

(3006245) CD3-CD19+ cells/cells in Blood

274

1188

2.32

36.82

3.1

2.3

9.50

10.96

1.01

258

1113

(3004119) Hemoglobin [Mass/volume] in Venous blood

2417

18472

1.33

36.81

4.1

3.5

129.92

128.82

g/l

1.66

2334

17991

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1905

14068

1.38

36.30

1.6

1.7

1.56

1.53

g/l

0.74

1649

12070

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

108

283

3.82

36.00

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

545

3057

1.79

35.84

1.2

21.33

32.95

nmol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

703

2.71

35.77

1.1

—

(3023419) Bacteria identified in Sputum by Culture

629

3680

1.72

35.72

2.8

2.6

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

263

1137

2.32

35.60

3.1

2.1

28.96

29.06

0.04

257

1083

(3011397) Hemoglobin [Presence] in Urine by Test strip

8263

72643

1.18

35.36

4.7

3.8

0.53

0.27

0.87

699

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

233

958

2.44

35.31

1.3

1.2

112.00

110.36

0.38

211

867

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

211

831

2.55

35.05

2.4

1.9

2.05

1.72

ratio

2.03

205

798

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

642

3811

1.70

34.59

1.9

2.2

32.49

32.43

0.13

636

3787

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

243

1028

2.37

34.58

1.3

0.31

0.30

g/l

0.92

190

834

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

169

4.68

34.36

1.0

1.1

8.54

9.05

u/l

0.10

169

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3999

32905

1.24

33.85

9.0

6.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1119

7605

1.49

33.77

1.5

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

448

2422

1.86

33.25

1.3

1.2

106.06

110.66

pmol/l

1.17

448

2422

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

293

1364

2.16

33.20

1.6

3.41

9.42

nmol/l

0.79

237

1139

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7728

67900

1.18

32.82

4.7

4.6

22.18

22.15

0.06

3548

34064

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8324

73600

1.17

32.71

2.7

2.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

383

1979

1.95

32.64

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

233

996

2.35

32.43

1.5

1.4

97.14

227.96

nmol/24h

1.86

233

996

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

540

3118

1.74

32.19

1.2

37.93

44.81

u/ml

0.24

156

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

384

2005

1.92

31.75

1.2

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

147

4.77

31.16

1.5

11.89

14.12

0.29

110

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

121

5.21

31.08

1.3

1.4

2.78

0.98

1.05

(3051387) C reactive protein [Mass/volume] in Capillary blood

882

5841

1.52

30.18

4.2

3.3

24.00

27.57

mg/l

2.46

633

4044

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4011

33391

1.23

30.17

2.3

2.2

—

(3042517) Benzodiazepines panel - Urine

104

304

3.43

29.56

3.2

2.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2048

15766

1.32

29.46

4.0

3.1

1.34

1.23

4.48

2038

15697

(3020717) Zinc [Moles/volume] in Serum or Plasma

328

1671

1.97

29.19

1.4

1.5

23.10

22.52

umol/l

0.13

310

1551

(3016038) Potassium [Moles/volume] in Urine

368

1949

1.90

29.19

1.4

1.3

33.64

34.48

mmol/l

0.27

324

1693

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

901

6038

1.51

29.16

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

901

6038

1.51

29.16

1.4

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2893

23327

1.26

28.99

2.6

2.8

69.36

65.89

ml/min/173m2

4.94

1295

9872

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

428

7414

0.57

28.92

1.4

1.5

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

366

1943

1.89

28.83

2.1

3.7

83.54

166.88

nmol/l

6.14

360

1915

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6134

53365

1.18

28.68

3.7

3.0

1.01

1.16

e6/l

1.48

3437

28264

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

439

7531

0.58

28.60

1.4

1.5

1.27

1.18

ratio

0.93

240

4572

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

439

7531

0.58

28.60

1.4

1.5

0.98

0.95

ratio

0.91

239

4530

(4024509) Urine culture

1767

13394

1.34

28.30

2.2

1.9

—

(3000060) B lymphocytes [#/volume] in Blood

210

913

2.31

28.19

3.2

2.2

0.16

0.88

e9/l

1.44

100

444

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

439

7499

0.58

28.15

1.4

1.5

1.12

1.16

ratio

0.47

239

4499

(3014765) Yersinia sp identified in Stool by Organism specific culture

1131

7986

1.43

27.97

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

241

1114

2.17

27.90

1.1

98.18

95.98

0.47

201

868

(42529406) Shigella sp [Presence] in Stool by Culture

1132

8000

1.43

27.86

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1177

8383

1.42

27.74

2.0

10.55

13.18

iu/l

0.14

486

3428

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2850

23086

1.26

27.39

2.7

2.3

12.08

12.55

nmol/l

2.38

2552

20755

(3019420) Tryptase [Mass/volume] in Serum or Plasma

320

1654

1.94

27.34

1.5

9.33

8.55

ug/l

0.20

295

1512

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2853

34900

0.80

27.31

5.1

4.9

32.24

32.64

1.18

2019

23538

(3052851) Hemolysis interference index of Serum or Plasma

1158

8265

1.41

26.97

3.3

2.13

2.22

index

0.15

645

4181

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1119

7939

1.42

26.95

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

1004

6986

1.45

26.89

3.2

3.3

1.51

1.57

mmol/l

0.93

976

6824

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

154

4.36

26.74

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

405

2274

1.79

26.68

1.3

2.54

2.18

u/ml

0.17

234

1347

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

285

1434

1.99

26.34

1.8

1.9

146.78

149.11

0.17

273

1346

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

103

324

3.18

26.09

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3439

28577

1.23

26.08

3.0

2.5

45.87

47.91

u/l

0.09

2919

24198

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

146

557

2.63

26.03

3.3

7.2

71.54

69.58

0.41

125

426

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1238

9001

1.39

25.88

1.4

1.3

—

159.43

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2545

20482

1.26

25.81

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

130

4.62

25.78

1.1

1.4

—

18931.36

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

487

2909

1.68

25.76

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

133

488

2.73

25.61

1.1

1.4

18.75

389.11

titre

—

(3044927) Protein electrophoresis panel - Urine

466

2757

1.70

25.55

1.1

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2008

15726

1.29

25.36

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

110

366

3.01

25.34

1.1

—

(3024928) Oxygen saturation in Venous blood

1065

7578

1.42

25.25

4.7

3.4

62.78

61.75

0.79

1024

7310

(3037121) Protein [Mass/volume] in Urine

1361

10093

1.36

25.18

2.8

3.5

408.06

469.88

mg/l

0.35

545

4753

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1096

7850

1.41

25.03

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

638

9695

0.65

24.88

1.1

0.65

0.62

ratio

0.33

1205

(3000012) Reticulocyte production index

647

4180

1.56

24.86

2.0

2.2

0.98

0.90

2.19

421

2868

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

662

4309

1.55

24.60

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

493

7910

0.62

24.58

1.5

61.25

62.16

ug/l

0.17

403

6581

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

642

4153

1.56

24.53

1.1

118.84

117.14

0.68

577

3764

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9402

85338

1.14

24.23

5.4

5.7

2.72

3.36

ug/l

0.90

8555

77069

(3043238) Trisomy 21 risk [Likelihood] in Fetus

367

6313

0.58

24.20

1.5

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

483

2929

1.66

24.15

1.1

—

61.25

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

440

2606

1.70

24.06

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5594

48929

1.17

23.94

3.9

3.1

3.27

2.86

e6/l

1.68

2867

23737

(3005033) Fetal Nuchal fold Thickness US

350

6077

0.57

23.91

1.5

1.27

1.26

0.14

241

4432

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

966

6824

1.43

23.86

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

603

3871

1.57

23.84

1.3

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

692

4584

1.52

23.73

1.3

1.2

3.48

3.67

u/ml

0.11

267

1759

(3002079) Sodium [Moles/time] in 24 hour Urine

260

1327

1.97

23.15

1.2

152.61

158.80

mmol/24h

0.63

260

1327

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

290

1536

1.89

23.12

1.1

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

202

941

2.15

23.03

1.1

94.54

88.77

1.26

116

429

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

147

4.15

22.95

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

363

6173

0.58

22.94

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

587

3781

1.56

22.89

1.3

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

619

4038

1.54

22.81

1.8

2.1

7.00

9.99

titre

0.26

(3004616) Nuclear Ab [Presence] in Serum

584

3764

1.56

22.72

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

326

3.01

22.64

3.5

3.2

40.09

41.26

umol/l

0.21

276

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1276

9544

1.35

22.34

2.5

2.6

95.35

92.69

4.11

1215

9191

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

706

10285

0.68

22.28

1.1

1.51

1.53

g/l

1.15

706

10276

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

205

976

2.11

22.12

1.4

14.16

15.02

pmol/l

1.58

172

818

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1296

9731

1.34

22.12

3.5

3.3

0.35

iu/ml

0.03

739

5333

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

694

4673

1.49

22.04

1.2

1.21

0.95

0.21

164

(40759836) Histone Ab [Presence] in Serum by Immunoblot

425

2556

1.67

21.99

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.90

21.70

1.9

2.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

354

2035

1.75

21.62

1.3

1.4

13.35

12.46

umol/l

1.33

331

1924

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1252

9396

1.34

21.44

3.0

2.7

3.54

3.57

g/l

0.28

1200

8995

(3024522) Salmonella sp identified in Specimen by Organism specific culture

581

3791

1.54

21.42

1.3

1.4

—

(3000492) Spirometry study

3394

28686

1.20

21.42

1.5

—

18.61

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

282

1521

1.86

21.30

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

230

1159

1.99

21.29

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

169

3.79

21.27

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2484

20366

1.24

21.23

2.2

2.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

622

4131

1.51

21.13

6.3

6.2

11.83

mg/l

0.01

578

3822

(3048929) Epstein Barr virus Ab [Presence] in Serum

1283

9710

1.33

20.76

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

269

1443

1.87

20.69

1.9

1.8

1.76

2.67

u/field

1.92

167

1031

(3033923) Metanephrine [Moles/time] in 24 hour Urine

132

538

2.46

20.63

1.1

0.73

0.81

umol/24h

0.28

255

(3020876) Protein [Mass/time] in 24 hour Urine

559

3648

1.54

20.61

2.6

2.5

1.35

1.20

g/24h

0.62

333

2147

(3038026) Centromere Ab [Units/volume] in Serum

377

2236

1.69

20.59

1.2

42.09

55.04

u/ml

0.34

151

(3004451) EKG impression Narrative

293

1617

1.82

20.58

1.4

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

321

1822

1.77

20.52

2.3

99.48

98.09

0.29

301

1717

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

659

4465

1.48

20.33

1.3

3.69

3.83

u/ml

0.14

298

2102

(3013005) Retinol [Moles/volume] in Serum or Plasma

264

1416

1.87

20.32

1.7

2.1

1.97

1.93

umol/l

0.31

242

1306

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

669

4548

1.48

20.30

1.1

766.43

3031.25

iu/ml

0.42

175

888

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1184

8890

1.34

20.22

2.7

2.6

182.22

191.74

3.27

1109

8458

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

198

965

2.06

20.13

1.1

91.92

89.58

0.54

112

433

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1332

10183

1.32

20.10

2.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

270

3.08

19.98

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2085

16893

1.25

19.83

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

809

5728

1.42

19.80

1.4

—

(4195642) Thrombophilia screening test

616

4144

1.49

19.70

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

661

4511

1.47

19.68

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

761

10692

0.70

19.66

1.2

0.89

0.88

g/l

0.06

756

10653

(3016650) Hepatitis A virus Ab [Presence] in Serum

704

4865

1.46

19.65

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

200

988

2.03

19.62

1.1

1.2

116.62

106.64

2.68

184

904

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

104

387

2.69

19.61

1.8

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

873

6277

1.40

19.56

2.2

1.9

189.58

196.21

pmol/l

0.98

820

5946

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

398

2430

1.64

19.49

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

878

6324

1.40

19.48

5.1

6.0

677.51

1083.57

iu/ml

0.64

108

952

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

568

3767

1.52

19.46

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

1127

8449

1.34

19.46

1.2

1.3

107.02

129.11

titre

0.85

131

784

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

425

2640

1.62

19.42

1.2

70.86

70.37

u/ml

0.01

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

309

1764

1.76

19.40

1.6

2.6

817.48

1108.87

u/ml

2.18

303

1743

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

409

2518

1.63

19.38

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

1110

8312

1.35

19.32

1.2

633.53

988.87

titre

1.68

231

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

409

2522

1.63

19.26

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

334

1955

1.71

19.19

2.8

2.6

0.87

0.68

e9/l

3.29

316

1876

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

336

2.80

19.15

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

387

2366

1.64

18.87

1.2

—

(3042631) Mycobacterium sp identified in Specimen

566

3778

1.51

18.83

2.9

2.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

197

983

2.01

18.82

2.1

2.8

1.50

1.21

ug/l

0.81

187

939

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

520

3413

1.53

18.73

1.8

1.7

401.53

365.84

mu/l

0.75

448

2731

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

859

6228

1.39

18.35

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

394

2442

1.62

18.20

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

699

4906

1.43

18.00

3.5

1.41

1.50

0.28

657

4365

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

449

2880

1.57

17.95

1.4

1.3

1.60

1.43

nmol/l

2.38

403

2601

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

166

3.56

17.95

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

181

894

2.03

17.82

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

211

1109

1.91

17.37

2.1

2.2

60.51

63.46

ug/l

0.28

205

1088

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

789

5698

1.39

17.28

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

472

3090

1.53

17.24

1.5

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

255

1426

1.79

17.24

1.6

1.5

1855235.29

1999905.36

iu/ml

0.08

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

298

1743

1.72

17.23

1.5

1.3

4.06

5.07

umol/l

4.95

265

1539

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

813

5911

1.38

17.10

1.3

262.05

263.92

u/ml

0.07

508

3714

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

274

1577

1.74

16.80

3.1

1.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1029

7782

1.33

16.79

1.1

7.02

6.08

eliau/ml

0.12

1002

(3027923) C peptide [Moles/volume] in Serum or Plasma

280

1624

1.73

16.71

1.6

1.5

1.21

1.27

nmol/l

0.37

231

1206

(21494890) Protein electrophoresis panel - 24 hour Urine

454

2969

1.54

16.69

2.0

2.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

233

3.01

16.29

1.7

1.6

0.90

1.87

mg/l

1.80

169

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

853

6304

1.36

16.23

1.3

24.52

52.49

u/ml

—

(21491868) Cryoglobulin [Mass/volume] in Serum

197

1037

1.90

16.19

1.2

0.32

0.53

g/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1089

14064

0.77

16.11

1.5

1.6

1053.88

1006.93

mu/l

0.73

924

11859

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

236

2.97

15.94

1.4

8.82

15.57

pmol/l

1.57

196

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

257

1478

1.74

15.84

2.4

2.3

196.24

202.68

u/l

0.87

257

1465

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5316

47591

1.14

15.75

1.7

—

(4268621) Lupus anticoagulant assay

477

3195

1.50

15.69

2.2

2.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

688

4941

1.40

15.62

2.6

3.2

9377.52

6542.99

u/ml

0.12

303

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

116

3.88

15.56

1.4

1.6

0.22

0.26

u/l

0.07

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

833

6184

1.36

15.42

1.4

1.5

22.47

22.00

u/ml

—

120

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

704

5100

1.39

15.19

1.2

1.1

16.23

16.00

au/ml

0.03

133

1265

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

357

2261

1.58

15.17

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

135

638

2.12

15.04

1.8

1.4

0.30

0.34

mmol/l

0.07

118

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1093

8490

1.30

14.74

2.0

1.8

42.35

42.74

nmol/l

0.18

1072

8278

(44790049) Parainfluenza type 3 nucleic acid detection

554

3875

1.44

14.63

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

526

3645

1.45

14.60

1.3

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

554

3877

1.44

14.59

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

554

3877

1.44

14.59

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

524

3630

1.45

14.57

1.3

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

367

2362

1.56

14.57

1.8

3.67

3.89

mg/l

0.42

353

2255

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

480

3271

1.47

14.54

2.8

3.5

4.33

9.88

nmol/l

1.56

463

3163

(3034274) Bile acid [Moles/volume] in Serum --fasting

568

3997

1.43

14.51

2.0

2.3

6.63

7.52

umol/l

0.53

420

2936

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1184

9311

1.28

14.51

4.6

4.3

1.49

1.54

mg/l

0.95

1082

8530

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

525

3642

1.45

14.50

1.3

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

353

2255

1.57

14.48

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

553

3876

1.43

14.45

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

157

799

1.97

14.32

2.8

3.2

1.96

1.86

ratio

0.45

144

734

(3004716) Salmonella sp identified in Stool by Organism specific culture

1717

14115

1.23

14.26

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3397

29669

1.16

14.22

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

660

4794

1.38

14.05

1.5

0.33

0.39

nmol/l

1.06

495

3664

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

126

3.57

13.87

1.6

1.5

613.37

475.37

nmol/l

0.72

126

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.36

13.74

1.4

1.6

205.82

213.95

nmol/l

0.05

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

550

3888

1.42

13.73

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

392

2.38

13.68

1.2

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

5.85

13.49

1.2

1.4

17.88

87.97

e6/l

1.55

(40761539) Cells [Type] in Urine sediment by Light microscopy

133

657

2.03

13.23

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

320

2.50

13.20

2.3

2.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

758

5684

1.34

13.20

1.4

1.5

152.62

146.98

au/ml

0.58

185

1661

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

373

2468

1.52

13.11

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

373

2468

1.52

13.11

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

373

2468

1.52

13.11

1.5

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

244

3965

0.61

13.06

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

3.12

12.94

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

497

3495

1.43

12.81

1.6

58.86

57.52

0.30

303

2209

(3049233) Organic acids panel - Urine

4.83

12.80

1.2

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

14.00

12.71

1.1

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1006

7910

1.28

12.40

1.4

1.5

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

232

2.72

12.30

1.7

1.6

2.97

1.73

mg/l

0.77

150

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

232

2.72

12.30

1.7

1.6

2.65

2.10

mg/l

0.26

181

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

232

2.72

12.30

1.7

1.6

1.62

1.59

mg/l

0.02

175

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

232

2.72

12.30

1.7

1.6

3.57

2.72

mg/l

0.36

170

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

232

2.72

12.30

1.7

1.6

4.42

4.08

mg/l

0.14

156

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

232

2.72

12.30

1.7

1.6

1.09

0.86

mg/l

0.15

166

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

232

2.72

12.30

1.7

1.6

2.13

2.42

mg/l

0.13

170

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

232

2.72

12.30

1.7

1.6

1.58

1.19

mg/l

0.25

154

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

232

2.72

12.30

1.7

1.6

1.80

2.01

mg/l

0.08

164

(3050129) First trimester maternal screen panel - Serum or Plasma

710

9361

0.75

12.29

1.4

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

699

5236

1.34

12.29

1.6

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

342

2254

1.52

12.28

1.9

2.0

1.67

2.88

u/field

0.60

176

1259

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

338

2223

1.53

12.26

1.6

26.11

25.22

u/ml

0.09

437

(3022493) Free Hemoglobin [Mass/volume] in Plasma

223

1329

1.68

12.21

4.0

81.97

1596.50

mg/l

2.75

159

959

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

508

3621

1.41

12.16

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

280

2.54

12.11

1.3

1.2

1.95

1.58

iu/ml

0.97

142

(3028679) Herpes simplex virus Ab [Presence] in Serum

262

1636

1.61

11.94

1.2

—

(3012565) Volume of 24 hour Urine

232

1410

1.65

11.80

2.2

1935.96

1936.04

0.00

206

1251

(3034891) Synovial lining cells/cells in Synovial fluid

225

1357

1.66

11.79

1.5

3.29

3.82

0.19

295

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

242

1488

1.63

11.76

1.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

241

1486

1.63

11.58

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

241

1486

1.63

11.58

1.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

241

1486

1.63

11.58

1.5

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

888

6940

1.29

11.51

1.4

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

576

4236

1.37

11.46

1.1

3.35

2.74

0.53

686

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

4.38

11.40

1.5

1.7

454.23

183.33

nmol/l

1.09

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

650

4874

1.34

11.39

1.3

—

17.60

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

261

1652

1.58

11.27

3.1

2.7

42.38

38.73

2.91

195

882

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

758

5822

1.31

11.22

2.4

2.0

0.97

0.85

nmol/l

4.24

654

4922

(3017354) Segmented neutrophils/Leukocytes in Blood

453

3213

1.41

11.20

3.6

3.5

56.62

57.71

0.53

419

2723

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

469

3352

1.40

11.11

1.1

—

(3017704) Immunofixation for Urine

246

1547

1.59

10.94

1.6

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

104

509

2.05

10.72

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

381

2642

1.45

10.69

1.5

29.29

31.11

0.40

205

1643

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

256

2.50

10.65

1.2

1.1

1.60

1.75

umol/24h

0.57

256

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

374

2.22

10.57

1.1

1.0

0.21

0.30

u/ml

0.16

237

(3024891) Influenza virus A+B Ag [Presence] in Specimen

988

7915

1.26

10.48

1.2

1.1

—

(40768443) Skin Pathology biopsy report

1614

13640

1.19

10.11

1.3

1.2

—

(44806071) Cardiolipin IgM antibody measurement

376

2.18

10.03

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.31

10.01

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

227

1434

1.59

9.95

2.0

2.3

51.00

42.86

umol/l

0.24

154

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

822

6486

1.27

9.93

2.4

107.09

111.75

ug/min

0.12

515

3818

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

316

2147

1.48

9.90

1.4

12.30

12.99

u/l

1.23

304

2076

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

373

2622

1.43

9.77

2.6

2.8

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

202

2.62

9.77

1.4

1.5

15.35

16.24

pmol/l

0.18

176

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

342

2.22

9.75

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

402

2866

1.41

9.73

1.5

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

656

5044

1.31

9.71

1.2

1.3

25.11

34.61

u/l

2.73

577

4373

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

108

558

1.94

9.61

1.3

1.2

0.61

66.52

mg/l

2.58

403

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

679

5253

1.30

9.60

1.8

1.6

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

326

2.24

9.55

1.7

2.0

1.31

1.32

umol/l

0.04

249

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

646

4969

1.31

9.54

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1358

11366

1.20

9.48

1.6

17.18

17.67

u/ml

0.06

274

2694

(3020123) Porphyrins [Interpretation] in Serum or Plasma

160

2.81

9.47

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

296

2.30

9.45

2.2

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

233

1509

1.55

9.21

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

327

2271

1.44

9.18

1.1

10.11

7.64

iu/ml

0.93

588

(3000093) Morphology [Interpretation] in Blood Narrative

401

2890

1.39

9.14

1.2

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.75

9.02

1.1

—

mmol/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

339

4750

0.71

8.86

3.4

3.7

28.12

38.76

u/ml

1.80

330

4587

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.70

8.85

2.0

2.1

263.01

249.30

ug/l

0.14

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

131

740

1.77

8.84

1.7

1.6

9.73

9.30

ug/l

0.49

131

740

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

184

2.61

8.78

1.2

39.78

22.58

—

(3036180) Methadone [Presence] in Urine

4.37

8.59

3.5

2.2

—

(3044009) aPTT.lupus sensitive (LA screen)

229

2.40

8.49

1.1

1.2

—

(3013466) aPTT in Blood by Coagulation assay

148

2.77

8.43

1.0

1.1

38.69

37.14

0.34

124

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

588

4545

1.30

8.43

1.5

1.3

27.00

27.43

u/l

0.11

500

3703

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

276

1897

1.46

8.25

1.3

1.4

—

(3011648) Oxygen content in Venous blood

423

3131

1.35

8.23

4.7

3.0

10.97

10.89

0.14

418

3121

(3007463) Buprenorphine [Presence] in Urine

107

3.08

8.21

4.7

7.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

244

1641

1.49

8.14

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

433

3222

1.35

8.14

1.1

98.74

95.78

1.46

403

3022

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

107

584

1.83

8.13

1.3

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

963

7919

1.22

8.12

2.2

1.9

—

(3045177) Copper [Moles/volume] in Urine

4.74

8.09

1.1

0.23

0.48

umol/l

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

539

4145

1.30

8.06

1.1

1.52

1.51

g/l

0.16

510

3788

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

770

6196

1.25

7.97

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3571

32442

1.11

7.91

1.6

1.7

—

6.66

—

(3051611) Lipemic interference index of Serum or Plasma

399

2949

1.36

7.86

3.7

3.5

13.60

13.62

index

0.01

247

1663

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

505

1.88

7.85

1.2

65.96

69.43

ug/l

0.24

505

(3011335) Digoxin [Mass/volume] in Serum or Plasma

201

2.44

7.84

3.0

2.2

0.60

0.70

ug/l

1.54

201

(3019174) dRVVT (LA screen)

226

2.35

7.79

1.1

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

106

585

1.81

7.79

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

204

1335

1.53

7.78

2.5

2.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

277

1928

1.44

7.77

1.3

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

101

3.07

7.67

1.1

408.95

275.23

nmol/l

0.48

101

(1617658) Protocol used for examination of sentinel lymph nodes

131

2159

0.60

7.66

1.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

246

1680

1.47

7.64

1.2

1.1

25.00

22.56

u/l

0.19

218

1488

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

427

3204

1.34

7.63

1.2

68.87

63.20

u/l

0.27

379

2803

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

3.71

7.60

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

246

1691

1.46

7.40

1.2

1.1

83.80

82.20

u/l

0.10

220

1498

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

233

2.28

7.30

1.4

1.3

0.47

0.54

iu/ml

0.20

122

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

147

909

1.62

7.19

2.7

2.8

202.08

142.86

au/ml

0.67

135

(3018133) Calcium [Moles/volume] in Urine

110

632

1.74

7.10

2.1

2.74

2.66

mmol/l

0.18

105

577

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

537

1.81

7.10

2.4

2.3

7.56

7.46

mmol/l

0.08

330

(3003694) ABO and Rh group [Type] in Blood

8951

84999

1.07

7.04

1.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

167

1071

1.56

7.02

2.0

1.9

161.35

168.14

0.38

158

1017

(3000475) Leukocytes [#/volume] in Synovial fluid

900

7465

1.21

7.02

1.6

16711.96

13417.68

e6/l

0.82

682

5280

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

247

1718

1.44

7.01

1.5

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.61

7.00

1.7

1.3

168.86

137.13

nmol/l

0.31

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12376

118821

1.07

6.99

2.0

1.9

1.42

1.34

mmol/l

14.55

10428

100062

(44813793) Dust mix specific IgE antibody measurement

300

2164

1.39

6.94

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

404

3055

1.33

6.89

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

563

7072

0.79

6.86

5.2

4.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

261

1844

1.42

6.81

1.5

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.33

6.80

1.1

1.2

28.37

50.23

umol/24h

0.55

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

3.33

6.80

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

158

1010

1.57

6.76

3.3

3.7

8.42

8.40

mg/l

0.01

134

810

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

254

2.17

6.76

1.1

1.0

0.04

0.05

u/ml

0.17

254

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

469

1.83

6.64

2.3

2.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

399

1.91

6.60

5.7

5.4

56.65

41.09

ug/min

0.96

312

(4094501) Cardiovascular stress test using bicycle ergometer

935

7834

1.20

6.58

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

269

1927

1.40

6.51

3.1

22.39

25.49

mu/l

0.73

253

1817

(3036071) Salmonella sp Ab [Titer] in Serum

137

857

1.60

6.45

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

265

1897

1.40

6.45

1.3

52.00

71.79

titre

0.55

140

(3034988) Calcium [Moles/volume] in Capillary blood

519

1.77

6.37

1.6

3.0

1.19

mmol/l

0.65

496

(3028433) Virus identified in Specimen by Culture

142

899

1.58

6.36

1.1

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

270

1947

1.39

6.30

1.3

92.50

518.37

titre

4.90

147

(3017950) Salicylates [Moles/volume] in Serum or Plasma

3.33

6.25

2.8

1.5

1180.40

1551.17

umol/l

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

109

649

1.68

6.25

1.1

1.2

85.97

86.66

0.04

172

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

109

649

1.68

6.25

1.1

67.48

74.63

0.84

164

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

2.86

6.17

1.0

9846.29

9014.12

ng/l

0.28

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

160

1050

1.53

6.13

2.5

2.8

0.61

mmol/l

0.08

160

1050

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1297

11256

1.16

5.99

4.5

4.4

24.79

24.75

mmol/l

0.23

1199

10390

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.45

5.99

1.3

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

24005

235752

1.07

5.95

28.8

20.5

332.27

332.16

g/l

1.10

23881

234429

(3035947) Staphylolysin Ab [Units/volume] in Serum

204

1417

1.44

5.92

1.1

2.80

4.14

iu/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

315

2356

1.34

5.87

1.1

—

(4281824) Cell count and differential, peritoneal fluid

237

3274

0.72

5.86

1.2

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.39

5.84

1.0

1.1

2.10

2.85

0.96

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

149

974

1.53

5.84

1.3

1.4

486.70

703.79

mu/l

0.95

144

929

(3042951) Complement C1q Ab [Units/volume] in Serum

125

2.56

5.76

1.8

1.2

29.72

18.29

u/ml

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

137

2.48

5.74

1.2

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

133

851

1.56

5.74

1.1

64.18

10.47

u/ml

0.40

504

(43055514) Macroprolactin [Presence] in Serum or Plasma

118

735

1.61

5.71

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

244

1765

1.38

5.65

1.5

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

314

2363

1.33

5.63

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

502

1.73

5.63

2.3

1.9

—

(37208534) Antinuclear antibody arbitrary concentration in serum

155

1031

1.50

5.62

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

150

991

1.52

5.62

1.3

1.4

73.22

73.43

0.07

145

946

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

323

2444

1.32

5.59

1.2

76.95

196.48

titre

8.72

401

(3010370) Gastrin [Moles/volume] in Serum or Plasma

475

1.75

5.54

1.5

1.9

90.55

51.38

pmol/l

0.34

403

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

418

1.80

5.48

1.6

1.5

7.41

198273.25

nmol/l

2.07

346

(3036603) Volume of Urine

300

2254

1.33

5.46

1.6

2238.14

1954.75

2.43

295

2200

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

321

2439

1.32

5.41

1.2

317.00

160.92

titre

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

105

645

1.63

5.40

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

413

1.79

5.39

2.6

2.3

1.78

1.32

mmol/l

0.58

290

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

152

1018

1.49

5.36

2.1

2.2

9.35

9.06

mg/l

0.26

128

849

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

488

1.72

5.33

2.8

2.7

45.31

45.43

mg/l

0.00

121

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

241

1762

1.37

5.26

1.6

1.5

7.69

6.92

u/l

0.38

187

1409

(3002621) Streptococcal DNAse B [Units/volume] in Serum

309

1.91

5.25

1.0

1.1

268.13

290.01

u/ml

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

764

6426

1.19

5.24

1.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

175

2.23

5.22

1.0

1.1

0.41

2.13

u/ml

1.13

126

(3012864) Amino acids [Identifier] in 24 hour Urine

+∞

5.21

1.2

0.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.22

5.15

1.0

0.10

0.99

u/ml

1.18

(3018001) Oat IgE Ab [Units/volume] in Serum

203

2.12

5.09

1.1

1.0

0.16

0.32

u/ml

0.66

118

(3014271) Vancomycin [Susceptibility]

192

1362

1.41

5.03

3.3

2.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

116

2.50

5.01

3.7

4.0

—

(3033099) Centromere Ab [Titer] in Serum

118

761

1.55

4.99

1.1

—

(3035060) Mercury [Moles/volume] in Blood

5.00

4.93

1.8

2.0

5.64

16.88

nmol/l

1.70

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

538

1.66

4.92

1.8

3.0

1.21

1.19

mmol/l

1.60

516

(3042111) Morphology [Interpretation] in Bone marrow Narrative

583

4813

1.21

4.91

1.6

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

461

3722

1.24

4.82

1.8

2.0

23.56

25.51

ug/l

0.20

452

3648

(3017315) Amylase [Enzymatic activity/volume] in Urine

217

1584

1.37

4.82

1.1

1.3

244.61

323.34

u/l

0.95

199

1469

(3005011) Chlamydia sp Ab [Titer] in Serum

384

1.77

4.81

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

343

2676

1.28

4.80

3.6

5.4

88.20

106.22

u/ml

0.25

113

887

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.82

4.80

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1168

10241

1.15

4.76

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

730

6175

1.19

4.74

2.6

3.5

1130.38

942.82

u/ml

0.08

640

5616

(3003577) Lead [Moles/volume] in Blood

217

2.03

4.68

1.2

1.4

0.14

0.24

umol/l

0.74

(3026250) Tacrolimus [Mass/volume] in Blood

189

1357

1.39

4.66

43.9

40.7

7.26

7.18

ug/l

0.17

178

1219

(3045683) HLA typing for celiac disease panel - Blood or Tissue

230

1706

1.35

4.64

1.0

—

(3003129) Base excess in Capillary blood by calculation

438

3535

1.24

4.62

2.3

0.73

0.48

mmol/l

0.73

413

3388

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

164

1153

1.42

4.57

1.5

2.1

40.62

40.07

g/l

0.48

164

1153

(3008896) Cortisol [Moles/volume] in Urine

10.00

4.51

1.1

1.0

242.87

90.50

nmol/l

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

290

1.86

4.51

1.0

0.03

1.20

u/ml

0.96

138

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

129

2.33

4.48

1.1

1.0

0.09

0.19

u/ml

—

(3047189) Immunofixation for 24 hour Urine

183

1318

1.39

4.45

1.7

1.8

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

350

1.77

4.42

1.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

246

1860

1.32

4.38

1.3

1.2

104.51

92.47

u/l

0.52

205

1593

(3013727) Leukocytes other/Leukocytes in Blood

128

866

1.48

4.38

3.3

3.5

56.00

52.42

1.23

122

839

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

265

1.89

4.36

1.1

1.0

0.53

0.57

u/ml

0.05

132

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

254

1932

1.32

4.34

1.5

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

684

5803

1.18

4.33

3.5

3.3

0.81

nmol/l

0.19

555

4643

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

441

3596

1.23

4.26

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

361

2883

1.25

4.22

1.3

6.35

6.29

mmol/l

0.15

339

2685

(3021661) Pineapple IgE Ab [Units/volume] in Serum

4.12

4.19

1.0

0.10

0.22

u/ml

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

272

2102

1.30

4.16

1.1

17.36

19.29

u/ml

0.27

833

(3020650) Glucose [Presence] in Urine

142

992

1.43

4.14

1.8

1.6

0.00

0.05

estimate

4.62

142

992

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

380

1.71

4.13

1.2

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

147

1035

1.42

4.11

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

638

5408

1.18

4.11

1.1

1.98

1.77

u/ml

0.22

355

2821

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

323

1.77

4.05

1.0

0.30

1.81

u/ml

0.61

154

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

771

6647

1.16

4.03

1.2

1.1

2.24

2.03

u/ml

0.22

474

3581

(3006576) Bicarbonate [Moles/volume] in Blood

135

940

1.44

4.02

5.7

6.5

25.15

24.99

mmol/l

0.18

124

860

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

5.55

3.96

1.2

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

2.42

3.95

1.3

1.5

654.04

902.32

nmol/l

0.59

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

378

1.69

3.94

1.0

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

454

3747

1.21

3.93

3.1

2.7

13.20

13.17

0.23

449

3702

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

106

709

1.50

3.89

1.3

41.60

37.95

0.46

462

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

133

931

1.43

3.86

1.1

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

315

1.75

3.79

1.0

0.02

0.73

u/ml

1.31

150

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

673

1.50

3.78

1.1

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

111

756

1.47

3.74

1.9

35.35

37.51

u/l

0.05

687

(3014133) Dog dander IgE Ab [Units/volume] in Serum

559

4730

1.18

3.72

1.1

4.43

4.12

u/ml

0.17

311

2403

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

202

1.93

3.69

1.4

2.1

197.42

178.28

ug/g

0.24

175

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

6.66

3.67

1.0

1.1

25.00

18.25

umol/l

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

519

1.56

3.64

2.1

1.6

0.17

0.23

nmol/l

1.28

374

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

235

1822

1.29

3.57

1.3

1.2

28.78

24.87

u/l

0.39

190

1531

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

397

1.64

3.56

1.1

—

(3025481) Topiramate [Mass/volume] in Serum or Plasma

6.15

3.49

1.5

2.5

4.52

8.42

mg/l

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

110

759

1.45

3.49

1.5

1.6

0.42

0.39

ug/l

0.24

544

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

228

1.84

3.48

1.2

1.1

13.63

19.06

iu/ml

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.70

3.48

1.1

1.0

0.04

0.22

u/ml

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

393

1.63

3.45

1.3

102.13

229.00

u/l

0.47

278

(40762365) Oxygen content in Arterial blood by calculation

440

1.59

3.43

2.5

3.0

15.08

14.75

ml/dl

0.44

412

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.98

3.40

1.9

1.2

1.23

2.09

g/l

1.51

(3002619) Bacteria identified in Specimen by Culture

112

782

1.43

3.36

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

519

1.52

3.22

1.6

—

(3007700) Barley IgE Ab [Units/volume] in Serum

136

2.06

3.20

1.1

1.0

0.19

0.53

u/ml

0.66

(40761995) Spermatozoa Progressive [#/volume] in Semen

488

0.49

3.16

2.0

3.4

39.96

44.70

0.66

488

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

487

0.49

3.15

3.9

6.7

9.71

8.63

0.40

487

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

117

2.14

3.14

1.1

1.0

0.02

0.10

u/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

123

885

1.39

3.14

1.2

1.3

37.62

40.41

g/l

1.41

450

(3032641) Amino acids panel - Urine

3.25

3.13

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

151

1.99

3.13

41.1

5.6

107.57

103.77

g/l

0.67

151

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

2.62

3.12

7.7

8.8

39.00

47.83

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

565

1.49

3.08

1.2

1.62

1.60

mmol/l

0.06

354

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1020

9140

1.12

3.07

1.4

1.5

—

(3007542) Rye IgE Ab [Units/volume] in Serum

152

1.97

3.07

1.1

1.0

0.14

0.39

u/ml

0.60

(4034850) Laboratory test

976

8731

1.12

3.04

19.2

9.5

—

(3034426) Prothrombin time (PT)

123

892

1.38

3.01

1.2

27.29

28.30

1.76

123

892

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

148

1961

0.75

3.00

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

481

4105

1.17

2.98

1.5

1.4

32.49

40.22

g/l

0.53

431

3733

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

132

971

1.36

2.97

1.1

1.0

7.58

10.16

u/ml

0.91

605

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

436

5126

0.85

2.95

1.5

58.54

60.21

ug/l

0.38

436

5126

(3000285) Sodium [Moles/volume] in Blood

547

1.48

2.93

1.2

137.64

138.40

mmol/l

0.57

470

(40768446) Kidney Pathology biopsy report

157

1188

1.32

2.93

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

366

3056

1.20

2.92

4.0

3.7

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

227

1.76

2.92

1.9

1.6

—

(3033086) Enterovirus Ab [Titer] in Serum

2.27

2.92

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

843

7497

1.13

2.91

1.2

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

171

1311

1.31

2.91

2.3

2.1

122.32

101.34

ug/min

0.18

290

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

338

2804

1.21

2.90

1.3

513.38

478.69

u/l

0.09

322

2661

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

480

4108

1.17

2.88

2.5

2.8

732.28

630.25

u/ml

0.09

471

4064

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

550

1.47

2.86

1.2

1.1

3.43

32.50

iu/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

429

3641

1.18

2.86

1.4

1.5

4294.95

2975.82

e6/l

0.27

321

2542

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

107

768

1.39

2.81

1.9

1.7

134.93

129.05

au/ml

0.04

108

(3035880) pH of Pleural fluid

195

1531

1.27

2.78

1.3

7.41

7.40

0.31

152

1065

(3027231) Wheat IgE Ab [Units/volume] in Serum

636

1.43

2.78

1.1

0.61

3.22

u/ml

1.52

551

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.64

2.78

1.1

1.0

0.21

1.85

u/ml

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

166

1277

1.30

2.78

3.3

1.30

1.29

0.02

166

1277

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

393

1.55

2.77

2.1

1.8

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

277

2265

1.22

2.77

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.08

2.76

1.1

—

(3000219) Insulin receptor Ab [Presence] in Serum

8.33

2.75

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

592

6759

0.87

2.74

1.5

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

106

765

1.39

2.71

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

226

1.73

2.68

1.1

1.0

0.17

1.06

u/ml

2.82

137

(3006270) Folate [Moles/volume] in Blood

274

2248

1.22

2.66

1.2

367.55

357.62

nmol/l

0.35

227

1875

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

311

1.61

2.64

1.2

1.4

78.33

70.98

1.07

255

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

220

1.73

2.63

1.4

2.9

2.40

57.71

pmol/l

—

(4146454) Self-monitoring of blood glucose

266

3228

0.82

2.62

2.8

—

(40759632) Porphyrins [Mass/mass] in Stool

3.60

2.57

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

130

979

1.33

2.56

1.1

1.0

0.30

0.72

u/ml

2.18

124

966

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

342

2879

1.19

2.55

3.5

3.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

143

1093

1.31

2.54

1.9

1.8

62185.80

19519.61

u/ml

0.41

158

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.60

2.52

1.2

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

164

1281

1.28

2.48

24.8

31.5

116.84

117.29

ug/l

0.03

123

1076

(3023383) Lactate [Moles/volume] in Pleural fluid

116

865

1.34

2.46

1.2

1.3

3.56

3.46

mmol/l

0.13

101

801

(3051101) Glucose [Moles/volume] in Cord blood

495

0.56

2.43

3.9

5.8

8.89

8.54

mmol/l

0.33

495

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1079

9836

1.10

2.42

1.3

1.4

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

273

1.61

2.38

1.6

1.4

14.49

17.55

nmol/l

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

418

1.48

2.34

1.7

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

432

3739

1.16

2.32

1.6

1.5

—

(3036005) Urine sediment comments by Light microscopy Narrative

3.10

2.22

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

104

1378

0.75

2.21

1.1

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

5.55

2.21

2.6

2.1

—

(3042628) Porphyrins [Moles/volume] in Urine

5.55

2.21

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

101

752

1.34

2.20

16.5

7.1

5.88

5.97

kpa

0.56

676

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

217

1.66

2.20

1.1

8.06

7.45

u/ml

0.07

134

(3004446) Plasmodium sp identified in Blood by Light microscopy

295

1.56

2.20

2.1

2.6

—

(3009015) Lactate [Moles/volume] in Synovial fluid

303

1.55

2.20

1.1

1.3

5.31

6.63

mmol/l

1.29

142

(3020618) Glucose [Moles/volume] in Synovial fluid

100

2.00

2.19

1.1

1.0

5.42

4.91

mmol/l

0.46

(3044416) Complement C4 [Mass/volume] in Pleural fluid

136

1.84

2.16

1.3

0.08

0.07

g/l

0.06

(3010144) Erythrocytes [#/volume] in Synovial fluid

327

2789

1.17

2.15

1.4

105446.63

138477.98

e6/l

0.48

220

1851

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

455

3982

1.14

2.13

1.1

0.22

0.40

u/ml

1.05

170

1294

(3012989) Citrate [Moles/time] in 24 hour Urine

2.36

2.11

1.5

1.4

2.31

1.92

mmol/24h

0.53

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

130

1.85

2.11

3.4

5.0

43891.43

386983.91

u/ml

—

(3022229) Phosphate [Moles/volume] in Urine

228

1.62

2.09

2.5

2.4

18.72

20.05

mmol/l

0.19

196

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

416

3623

1.15

2.09

2.2

2.0

23.37

26.66

mg/l

0.68

142

1329

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

339

1.50

2.09

3.0

2.4

0.59

0.63

u/field

0.12

339

(40768800) Prostate Pathology biopsy report

491

5558

0.88

2.09

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

429

1.45

2.09

1.1

—

(3013931) Oligosaccharides [Presence] in Urine

5.00

2.07

1.2

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

125

1.84

2.01

3.5

4.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

262

2211

1.19

1.99

1.3

14.04

14.08

u/l

0.01

235

2039

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

170

1.71

1.99

1.1

52.26

93.05

u/l

0.55

141

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

216

1.62

1.98

2.1

2.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

248

1.57

1.96

1.3

1.1

99.28

96.65

titre

0.07

248

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.08

1.95

7.9

8.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

427

1.43

1.95

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

452

1.42

1.95

2.1

1.3

124.35

300.59

ng/l

0.44

288

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.94

1.1

1.0

0.04

u/ml

0.05

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5250

50728

1.04

1.94

3.2

3.3

0.72

0.79

ug/l

5.94

3455

33820

(3038071) Oxygen [Partial pressure] in Mixed venous blood

675

1.33

1.91

17.6

6.9

6.39

5.49

kpa

2.26

675

(3042010) Triglyceride [Moles/volume] in Pleural fluid

454

1.41

1.91

1.2

1.3

0.98

1.40

mmol/l

0.28

295

(3020393) Adenovirus Ag [Presence] in Stool

389

1.44

1.88

1.5

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.18

1.87

1.7

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1045

9644

1.09

1.87

1.3

224.88

223.18

miu/ml

0.05

465

4388

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

182

1495

1.22

1.86

1.4

5.85

5.69

mmol/l

1.33

160

1420

(3025549) Creatine [Moles/time] in 24 hour Urine

220

1.59

1.86

1.5

1.4

—

14.25

—

(3014891) Appearance of Pleural fluid

366

1.45

1.84

1.8

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

646

1.33

1.83

2.5

2.6

515.78

377.81

ug/l

0.12

646

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.17

1.82

1.4

1.0

—

(3012441) Differential panel - Pleural fluid

355

3096

1.15

1.80

1.4

1.5

—

1.00

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.95

1.79

3.4

7.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

184

1521

1.21

1.78

1.4

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

649

1.33

1.78

1.0

1.1

32.07

29.36

iu/ml

0.16

649

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

184

1522

1.21

1.77

1.4

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

460

4086

1.13

1.77

1.1

1.80

3.36

eliau/ml

4.73

180

1871

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

430

1.40

1.72

1.2

1.3

42.22

40.88

mg/l

0.09

361

(3002256) Pathology report gross observation

4157

40081

1.04

1.72

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

709

0.70

1.72

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

338

2951

1.15

1.71

1.4

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

171

1.64

1.69

1.1

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

743

1.29

1.68

1.2

6.04

13.31

pmol/l

5.09

275

(3005082) Progesterone [Moles/volume] in Serum or Plasma

132

1629

0.81

1.67

1.4

1.5

29.51

34.95

nmol/l

0.96

121

1496

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

358

1.42

1.66

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

500

4485

1.12

1.65

1.1

5.74

5.08

u/ml

0.20

242

2078

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

597

1.32

1.64

1.1

1.2

2.99

8.41

u/ml

0.96

409

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

268

1.49

1.64

1.2

109.67

101.53

ug/l

0.12

165

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.44

1.64

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

555

1.33

1.62

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

245

2100

1.17

1.61

1.9

1.8

7.06

6.78

mmol/l

0.75

180

1528

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

205

1.56

1.61

1.0

1.2

39.93

45.09

mg/l

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

556

1.33

1.61

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

556

1.33

1.61

1.1

1.2

—

(3024316) Viscosity of Plasma

143

1.68

1.60

2.3

1.8

1.53

1.64

mpas

0.44

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

185

2198

0.84

1.59

1.3

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

489

1.35

1.58

2.2

2.8

2255.74

1525.60

u/l

0.20

436

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

327

2870

1.14

1.56

1.2

1.3

—

titre

—

(3026480) Teichoate Ab [Titer] in Serum

255

1.49

1.56

1.1

—

2.22

—

(3008536) Aspergillus sp Ab [Presence] in Serum

611

1.31

1.56

1.8

2.1

—

(3025130) Human papilloma virus identified in Specimen

430

4803

0.89

1.56

1.8

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

215

1.53

1.55

1.0

1.1

1.26

1.23

mom

0.09

215

(3035320) C reactive protein [Mass/volume] in Body fluid

276

2399

1.15

1.53

3.7

2.6

20.96

29.46

mg/l

4.62

206

1725

(3007147) Virus identified in Stool by Electron microscopy

3.33

1.52

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

649

1.29

1.52

1.2

281.69

304.36

pmol/l

0.27

466

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.59

1.51

2.3

2.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

255

2206

1.16

1.51

1.3

86.62

79.18

1.73

148

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

379

3368

1.13

1.50

2.4

2.5

26.39

26.35

iu/ml

0.00

340

(3046861) Legionella sp Ag [Presence] in Urine

177

1.58

1.50

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

183

0.49

1.49

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

144

1188

1.21

1.48

1.1

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

101

1.78

1.48

1.0

1.1

1.33

1.21

u/field

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

632

5782

1.09

1.46

1.1

3.94

4.89

u/ml

1.19

340

3118

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

211

1.52

1.44

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.11

1.44

1.9

2.4

2.01

3.45

mu/l

0.64

(37021550) Renin [Units/volume] in Plasma --upright

567

1.31

1.44

1.2

1.3

148.43

68.64

mu/l

0.36

417

(3026692) Albumin [Mass/volume] in Peritoneal fluid

779

1.26

1.43

1.5

1.3

11.55

13.84

g/l

2.06

586

(3034614) HLA Ag [Interpretation]

2.03

1.43

1.4

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

151

1259

1.20

1.41

1.6

1.7

3.48

2.53

u/ml

0.25

352

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

157

1314

1.20

1.41

1.2

9.52

10.40

mm/h

0.42

157

1314

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

320

1.41

1.40

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

491

1.32

1.40

1.6

104.48

110.11

ug/l

0.15

412

(40768795) Lymph node Pathology biopsy report

260

2970

0.87

1.39

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

365

3256

1.12

1.39

1.5

91968.21

51402.45

e6/l

1.10

222

1820

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

218

1879

1.16

1.38

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

305

1.41

1.37

1.0

0.01

0.29

u/ml

1.51

187

(3001964) Herpes simplex virus Ag [Presence] in Specimen

104

839

1.24

1.35

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

151

1.59

1.34

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

533

4865

1.10

1.32

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

416

3754

1.11

1.30

1.3

7.29

7.18

mmol/l

0.31

375

3291

(3041806) Other cells [#/volume] in Blood by Manual count

958

0.79

1.24

1.5

0.48

0.52

e9/l

0.71

958

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

278

1.40

1.23

3.4

3.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

162

1380

1.17

1.23

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

162

1380

1.17

1.23

1.3

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

131

1.60

1.22

1.1

0.09

0.08

0.43

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.63

1.21

1.2

1.1

20.40

15.26

umol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

152

1291

1.18

1.20

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.93

1.16

1.9

4.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

290

3241

0.89

1.15

2.8

2.4

1.20

mmol/l

0.02

290

3214

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

696

1.24

1.13

2.6

3.0

123.64

109.25

ng/l

0.31

382

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.68

1.13

1.1

—

(3048879) Bone marrow aspiration report

787

1.22

1.12

1.5

1.8

2.00

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.96

1.11

2.0

2.1

21.47

29.78

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.96

1.11

1.0

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

310

1.35

1.10

3.5

2.9

26.34

23.65

mg/l

0.68

291

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

707

6595

1.07

1.09

1.4

108.67

148.66

pmol/l

2.71

683

6434

(3026051) Granulocytes/Leukocytes in Pleural fluid

637

1.24

1.09

1.3

1.4

26.20

22.50

0.56

523

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

160

1.50

1.08

4.4

4.8

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

140

0.50

1.08

8.6

9.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

895

0.80

1.08

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.19

1.08

1.1

1.2

0.14

1.72

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

136

1.54

1.07

1.0

1.2

4151.36

3614.04

ng/l

0.12

(3043410) Blood group antigens tested for on Red Blood Cells

803

1.21

1.05

1.7

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

506

1.26

1.05

1.3

—

(3042733) HLA Ab [Presence] in Serum

116

977

1.19

1.05

4.8

4.9

—

(3026470) Cobalt [Mass/volume] in Blood

191

1676

1.14

1.02

2.1

2.2

4.01

3.63

ug/l

0.19

175

1550

(3007919) Fasciola sp Ab [Titer] in Serum

1.83

1.02

1.1

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

223

1977

1.13

1.02

1.1

1.05

2.04

u/ml

0.93

692

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

324

1.33

1.01

1.2

1.3

5.89

5.87

mmol/l

0.02

324

(3022475) Manganese [Moles/volume] in Blood

163

1.47

1.01

1.1

1.3

0.15

umol/l

0.01

163

(3029396) Erythrocyte agglutination [Presence] in Blood

831

0.81

1.00

3.2

3.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.00

1.00

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

265

1.36

0.99

1.9

1.8

44.72

47.53

umol/l

0.16

265

(3010937) Rubella virus Ab [Presence] in Serum

189

1.43

0.98

1.0

1.1

—

(3024263) Appearance of Synovial fluid

165

1439

1.15

0.98

1.4

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

377

4109

0.92

0.96

1.4

3.66

3.80

ug/l

0.10

322

3644

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

157

1.46

0.95

1.1

1.2

1.57

1.08

u/field

0.85

100

(3009871) Measles virus Ab [Titer] in Serum

132

1136

1.16

0.94

1.7

1.6

3448.56

3441.88

titre

0.00

181

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

328

1.31

0.94

1.1

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.65

0.94

1.1

1.0

0.32

0.18

u/ml

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

166

1.45

0.93

1.3

1.8

0.73

0.69

umol/l

0.20

130

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

208

1.39

0.93

1.0

0.06

1.91

u/ml

1.51

164

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.71

0.92

1.2

28.68

32.58

mg/24h

0.34

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.73

0.92

1.1

1.2

211.22

261.38

u/ml

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

564

0.78

0.90

1.5

1.9

1.62

2.72

ug/l

1.34

353

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

143

1.47

0.89

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

229

2058

1.11

0.87

1.4

1.6

8.21

7.78

mmol/l

2.44

216

1980

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

111

1.53

0.87

1.1

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.86

0.87

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.00

0.87

1.0

0.03

0.16

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

595

5577

1.07

0.86

1.1

0.58

1.00

u/ml

3.12

270

2533

(3024932) HLA-DR beta [Type]

104

887

1.17

0.86

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

121

1046

1.16

0.84

1.2

—

(4133840) Spirometry

723

1.19

0.84

1.2

—

(3024471) HLA-A [Type]

106

908

1.17

0.83

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

578

1.21

0.83

1.9

1.7

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

345

1.28

0.82

1.0

1.1

4.25

5.61

u/ml

0.18

275

(3035611) Eosinophils/Leukocytes in Synovial fluid

180

1.39

0.81

1.3

1.8

0.52

0.71

0.33

143

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

206

1.36

0.80

1.1

1.6

0.60

8.39

u/ml

1.67

178

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

46.41

—

(3050794) Legionella sp Ab [Presence] in Serum

252

1.31

0.76

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

123

1076

1.14

0.75

1.9

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

116

1.46

0.73

1.3

1.4

1.11

1.19

u/field

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

351

1.25

0.73

1.1

3.13

4.12

u/ml

0.17

280

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.84

0.73

1.0

—

(3045142) Bone marrow Pathology biopsy report

359

3333

1.08

0.72

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

629

5955

1.06

0.70

3.8

3.4

7.29

7.57

mmol/l

1.53

607

5824

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

126

1112

1.13

0.70

1.2

1126.09

1013.50

titre

0.28

237

(3016750) Collection duration of Urine

175

1576

1.11

0.69

2.5

2.2

498.42

500.16

min

0.08

132

1176

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

157

0.64

0.68

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.51

0.65

1.1

0.02

0.09

g/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

568

5378

1.06

0.65

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

171

1.34

0.65

1.3

1.5

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.60

0.61

1.1

1.2

23.11

29.40

mg/l

—

(3001556) Androgen free Index in Serum or Plasma

253

1.26

0.60

1.5

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

183

1.31

0.59

1.3

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

133

1195

1.11

0.58

1.1

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

246

1.26

0.57

1.1

0.03

0.68

u/ml

1.21

246

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

382

1.20

0.57

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1362

14042

0.97

0.57

1.8

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

127

1410

0.90

0.56

6.5

6.0

2069.65

3421.80

u/ml

0.16

235

(21494434) Karyotype in Bone marrow

282

2629

1.07

0.55

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

565

5380

1.05

0.55

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1056

10194

1.04

0.55

1.6

1.7

4.81

4.37

mg/l

0.58

836

7553

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

131

1449

0.90

0.55

1.4

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

159

1.32

0.55

5.1

3.4

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

367

1.20

0.53

1.4

1.2

20.15

20.64

mmol/l

0.35

319

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

843

1.13

0.53

1.2

1.3

180.93

288.86

ug/l

0.43

453

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

196

1.28

0.52

1.2

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

414

0.82

0.52

1.0

81.03

80.43

ug/l

0.02

315

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

262

2448

1.07

0.50

1.7

1.9

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

279

1.22

0.49

1.1

0.17

1.58

u/ml

2.36

205

(3018291) Platelet Ab [Presence] in Serum

1.55

0.48

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

280

1.21

0.48

1.3

1.2

0.24

0.40

u/ml

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

381

1.18

0.48

3.2

2.8

47.34

74.17

pmol/l

2.15

332

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.45

0.48

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

217

1.24

0.47

1.9

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

310

3283

0.94

0.47

2.7

2.4

4.03

4.06

mmol/l

0.69

310

3256

(44786800) Granulocytes/Leukocytes in Body fluid

332

0.81

0.46

1.2

1.3

23.90

24.14

0.01

255

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

755

7277

1.04

0.46

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

310

3280

0.94

0.46

2.7

2.4

105.49

105.66

mmol/l

0.26

310

3252

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

164

0.73

0.45

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.40

0.45

1.0

1.3

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

1.40

0.45

2.0

2.1

54.40

11.44

ng/l

—

(3006462) Nitrate [Presence] in Urine

146

1342

1.09

0.45

3.2

3.1

—

(3001729) Color of Synovial fluid

210

1.24

0.44

1.3

1.7

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.41

0.43

1.3

1.2

—

(4211845) Urine protein measurement

159

1471

1.08

0.42

3.1

3.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

377

1.17

0.42

14.1

9.6

0.37

0.42

umol/l

0.23

335

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

350

1.17

0.41

1.5

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

261

2462

1.06

0.41

3.0

67.19

46.87

mg/l

0.40

186

1758

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

1.47

0.40

1.0

1.2

78.60

85.42

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

184

1718

1.07

0.40

1.0

1.1

0.45

1.13

u/ml

1.05

467

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

177

1.24

0.40

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

140

1512

0.93

0.40

2.0

1.7

222.33

597.54

pmol/l

0.46

228

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.43

0.39

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.43

0.39

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.43

0.39

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.43

0.39

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.43

0.39

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.43

0.39

2.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.39

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

196

1.22

0.38

4.3

5.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

495

1.13

0.37

5.7

7.2

10.83

10.46

0.59

495

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

243

1.19

0.37

3.7

2.1

49.57

61.52

0.60

157

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

107

1.31

0.37

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

545

0.88

0.36

1.2

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

384

1.15

0.35

1.3

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

140

1302

1.07

0.35

1.8

2.5

19.32

235.27

ug/l

1.85

133

1236

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.33

0.35

2.1

2.3

0.08

0.35

ug/l

1.24

(3023487) Leukocytes [#/volume] in Peritoneal fluid

119

1100

1.08

0.35

2.5

1.9

820.34

3397.83

e6/l

1.50

729

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

153

1.24

0.35

15.6

10.0

92.54

236.63

e6/l

0.94

106

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

245

1.18

0.34

1.5

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

227

1.19

0.34

1.2

1.5

—

(3004775) Volume in Urine collected for unspecified duration

205

2167

0.95

0.33

2.4

2.3

665.52

673.10

0.10

148

1478

(4035726) Immunohistochemistry procedure

2622

25828

1.02

0.33

1.4

—

(3025577) Chromium [Mass/volume] in Blood

174

1637

1.06

0.33

2.2

2.50

2.28

ug/l

0.19

149

1356

(3022670) pH of Venous cord blood

0.68

0.33

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

109

1009

1.08

0.32

1.4

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

761

1.09

0.31

1.4

21.17

20.75

0.04

685

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

102

944

1.08

0.31

2.4

1.8

4721.71

12862.68

e6/l

1.48

480

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

239

1.17

0.31

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

1.32

0.30

1.6

1.3

0.41

2.71

mmol/l

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.71

0.30

1.0

162.71

164.39

g/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

277

1.15

0.30

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

287

1.15

0.29

1.0

9.53

9.15

mu/l

0.10

231

(3014599) Egg white IgE Ab [Units/volume] in Serum

201

1909

1.05

0.29

1.0

1.1

0.61

6.61

u/ml

1.93

532

(3032868) Hemoglobin electrophoresis panel in Blood

260

1.15

0.28

1.4

1.5

—

(3013862) HLA-DP [Type]

117

0.77

0.27

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

132

1.21

0.25

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1064

10837

0.98

0.25

2.6

3.6

1031.94

1423.93

u/ml

0.33

898

9346

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.22

0.25

1.0

3.31

3.53

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

177

1851

0.96

0.23

1.5

1.3

168.38

171.41

pmol/l

0.11

177

1851

(40758358) Immune stain study

125

0.80

0.23

1.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.24

0.22

1.8

1.4

124.17

128.14

ug/l

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.25

0.22

1.2

1.1

5000.00

3499.00

titre

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

247

1.13

0.22

1.4

1.3

1.34

1.52

ml/s/173m2

0.20

166

(40768806) Pleura Pathology biopsy report

319

3089

1.03

0.21

1.5

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

21.17

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

6.3

—

205.00

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

828

1.06

0.20

1.3

1.4

61.69

54.77

0.97

710

(3029612) Listeria sp Ab [Titer] in Serum

1.25

0.20

1.3

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

334

0.90

0.20

1.3

2.1

8.10

7.45

mmol/l

—

124

(40763590) HLA-DQ beta [Type]

114

0.79

0.20

1.0

—

(40760409) HLA-A [Type] by High resolution

115

0.78

0.20

1.0

—

(40760410) HLA-B [Type] by High resolution

115

0.78

0.20

1.0

—

(46236302) HLA-C [Type] by High resolution typing

115

0.78

0.20

1.0

—

(44806420) Estimation of glomerular filtration rate

316

3252

0.97

0.19

2.6

2.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.20

0.19

1.8

1.4

315.17

400.32

mg/24h

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

684

1.07

0.19

1.6

1.3

23.37

37.43

g/l

0.94

529

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

317

1.10

0.19

1.1

17.38

21.14

u/l

0.88

205

(40762814) Titanium [Mass/volume] in Blood

478

0.92

0.19

2.6

2.5

3.26

3.62

ug/l

0.38

186

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

350

3407

1.03

0.18

1.3

—

(4038314) Semen analysis, post vasectomy

132

0.83

0.18

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

413

0.92

0.17

1.1

1.0

12.81

10.12

u/ml

0.15

413

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

234

1.11

0.16

3.8

3.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3065

30855

0.99

0.16

3.1

4.3

18.12

25.20

ug/l

0.36

2406

25057

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.10

0.15

1.0

1.1

—

(3013762) Body weight Measured

1.10

0.15

1.4

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

181

1755

1.03

0.14

5.6

7.2

151.57

78.16

ug/l

0.29

100

1162

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

315

0.92

0.13

3.0

3.1

1.44

1.22

mg/l

0.31

230

(3027570) Oxalate [Moles/time] in 24 hour Urine

180

0.89

0.13

1.6

1.4

277.25

331.88

umol/24h

1.14

180

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

132

1.14

0.13

1.3

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

843

1.04

0.13

1.4

1.90

2.88

0.75

707

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

405

1.06

0.11

1.3

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

115

0.87

0.10

1.0

1.1

0.00

1.68

u/ml

—

115

(3005532) Lymphocytes/Leukocytes in Pleural fluid

102

986

1.03

0.10

1.4

69.95

63.24

1.28

804

(4212803) Bone marrow aspirate examination

242

1.07

0.09

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1593

15822

1.01

0.09

2.6

3.6

44.14

58.84

u/ml

1.65

1533

15294

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

194

1.08

0.08

3.7

2.1

16.22

18.21

—

(3003157) Bacteria [#/volume] in Mother's milk

1.07

0.08

7.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

215

0.93

0.07

5.5

3.4

13.08

11.60

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

480

1.04

0.07

1.6

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

177

1.07

0.06

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

1481

14868

1.00

0.06

3.7

3.4

1.02

ratio

2.27

1326

13357

(3044007) Cell count panel - Peritoneal fluid

929

0.98

0.05

2.5

1.8

—

(40765096) Chromosome analysis panel by Banding

868

0.98

0.05

1.2

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

169

1.06

0.05

1.1

1.2

—

314.00

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

120

1.08

0.04

1.2

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

221

0.95

0.04

4.0

5.7

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

131

1.07

0.03

1.3

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

179

0.95

0.03

1.1

—

(4015189) Microbial culture of sputum

727

1.02

0.03

2.1

2.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

209

0.96

0.03

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

114

1127

1.01

0.02

1.7

2.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

202

1.04

0.02

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

481

1.02

0.02

1.4

1.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

270

2686

1.00

0.01

1.2

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

113

1.06

0.01

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

112

1110

1.01

0.01

1.7

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

112

1110

1.01

0.01

1.7

2.0

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

423

1.02

0.01

1.4

9.14

11.67

0.44

213

(40768441) Liver Pathology biopsy report

224

2233

1.00

0.00

1.5

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

103

0.97

0.00

1.0

1.1

104.40

219.98

pmol/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

147

1.02

0.00

1.3

1.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

105

0.95

0.00

1.1

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

248

1.01

0.00

1.0

-1.79

-2.54

mmol/l

—

(3006598) pH of Arterial cord blood

248

1.01

0.00

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

131

1307

1.00

0.00

1.1

7.74

9.11

u/ml

0.18

220

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

5.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.95

-0.00

1.1

1.0

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

383.00

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.7

—

3.57

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

8.54

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS – Symptoms and signs involving the nervous and musculoskeletal systems

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Symptoms and signs involving the nervous and musculoskeletal systems

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Symptoms and signs involving the nervous and musculoskeletal systems (R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints